Psyllid ID: psy12232

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200--
Protein Sequence
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESNDDEETCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Secondary Structure (PSIPRED)
ccHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHccccccccEEccccccccccccccccccccHHHHHHHHHHHccccccEEccccEEEccccHHHHHHccccccccccccccHHHHHHHHHcccccEEEEEEEccHHHHHHHHHHHcccccccccEEEEEEEEcc
Secondary Structure Prediction (SSPRO)
ccEEHHHHHHHcccccccccHHHHHHHHHHHHHEccccccccHHcccccccccccccccccccccccccccccccEEEcccccHHHccEEEEEcccccHHHHHHHHHHHHHccccEEEEEcccEEEcHHHHHHHHcccccEEEEccccHHHHHHHHHHHHcccEEEEEEEccHHHHHHHHHHHHHHcHccccEEEEEEEccc
Coil and Loop (DISEMBL)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGqeyleleaplldtppssedesnddeETCAYLLESVIRISNLDGEQMKYLIqvnppgdilPEVIRAIILMQNItdagilfddsfifdHKYKSllqniptrhiiapvedsrsvkrqlfrfkdldivNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Flexible Loop (DISEMBL)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESNDDEETCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQniptrhiiapvedsrsvkrqlfrfkdldivNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Low Complexity Region (SEG)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPssedesnddeeTCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Disordered region (IsUnstruct)
*****LMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEA******************TCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL**
Disordered Region (DISOPRED)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILT**********YL********************************************************EVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVE******RQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLV*
Disordered Region (DISEMBL)
********DCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLD*************ETCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Disordered Region (DISPRO)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTP******************ESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLV*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESNDDEETCAYLLESVIRISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLVE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	202	2.2.26 [Sep-21-2011]
P18461	823	Fibroblast growth factor	yes	N/A	0.262	0.064	0.561	2e-09
Q03364	813	Fibroblast growth factor	N/A	N/A	0.247	0.061	0.574	3e-09
P21802	821	Fibroblast growth factor	no	N/A	0.262	0.064	0.561	4e-09
Q61851	801	Fibroblast growth factor	no	N/A	0.262	0.066	0.491	8e-09
P21803	821	Fibroblast growth factor	no	N/A	0.247	0.060	0.574	1e-08
P22607	806	Fibroblast growth factor	no	N/A	0.262	0.065	0.473	1e-08
Q04589	822	Fibroblast growth factor	no	N/A	0.326	0.080	0.465	1e-08
P11362	822	Fibroblast growth factor	no	N/A	0.326	0.080	0.465	2e-08
P16092	822	Fibroblast growth factor	no	N/A	0.326	0.080	0.465	2e-08
Q91286	824	Fibroblast growth factor	N/A	N/A	0.321	0.078	0.465	3e-08

>sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus GN=FGFR2 PE=2 SV=1

 Score = 62.4 bits (150), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/57 (56%), Positives = 36/57 (63%), Gaps = 4/57 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED 60
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    PS  D
Sbjct: 735 YMMMRDCWQAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSGPLEQYSPSYPD 787

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.
Gallus gallus (taxid: 9031)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|Q03364|FGFR2_XENLA Fibroblast growth factor receptor 2 OS=Xenopus laevis GN=fgfr2 PE=2 SV=1

 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/54 (57%), Positives = 35/54 (64%), Gaps = 4/54 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPS 57
           Y +MRDCW  + S RP F QLV  LDRILT+T NE    EYL+L APL    PS
Sbjct: 723 YMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE----EYLDLSAPLEQYSPS 772

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P21802|FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1

 Score = 61.2 bits (147), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/57 (56%), Positives = 36/57 (63%), Gaps = 4/57 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED 60
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    PS  D
Sbjct: 733 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSPSYPD 785

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q61851|FGFR3_MOUSE Fibroblast growth factor receptor 3 OS=Mus musculus GN=Fgfr3 PE=1 SV=1

 Score = 60.5 bits (145), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 28/57 (49%), Positives = 35/57 (61%), Gaps = 4/57 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED 60
           Y +MR+CW  V S+RP F QLV  LDRILTVT+ +    EYL+L  P     P  +D
Sbjct: 719 YMIMRECWHAVPSQRPTFKQLVEDLDRILTVTSTD----EYLDLSVPFEQYSPGGQD 771

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of STAT1, STAT5A and STAT5B. Plays a role in postnatal lung development.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P21803|FGFR2_MOUSE Fibroblast growth factor receptor 2 OS=Mus musculus GN=Fgfr2 PE=1 SV=4

 Score = 60.1 bits (144), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/54 (57%), Positives = 35/54 (64%), Gaps = 4/54 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPS 57
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    PS
Sbjct: 733 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLTQPLEQYSPS 782

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P22607|FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1

 Score = 59.7 bits (143), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 35/57 (61%), Gaps = 4/57 (7%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED 60
           Y +MR+CW    S+RP F QLV  LDR+LTVT+ +    EYL+L AP     P  +D
Sbjct: 724 YMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTD----EYLDLSAPFEQYSPGGQD 776

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus GN=Fgfr1 PE=1 SV=1

 Score = 59.7 bits (143), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/73 (46%), Positives = 44/73 (60%), Gaps = 7/73 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +MRDCW+ V S+RP F QLV  LDRI+ +T+N    QEYL+L  PL    PS  D  +
Sbjct: 730 YMMMRDCWNAVPSQRPTFKQLVEDLDRIVALTSN----QEYLDLSMPLDQDSPSFPDTRS 785

Query: 64  DDEETCAYLLESV 76
               TC+   +SV
Sbjct: 786 S---TCSSGEDSV 795

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3

 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/73 (46%), Positives = 43/73 (58%), Gaps = 7/73 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N    QEYL+L  PL    PS  D  +
Sbjct: 730 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN----QEYLDLSMPLDQYSPSFPDTRS 785

Query: 64  DDEETCAYLLESV 76
               TC+   +SV
Sbjct: 786 S---TCSSGEDSV 795

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus GN=Fgfr1 PE=1 SV=2

 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/73 (46%), Positives = 43/73 (58%), Gaps = 7/73 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N    QEYL+L  PL    PS  D  +
Sbjct: 730 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN----QEYLDLSIPLDQYSPSFPDTRS 785

Query: 64  DDEETCAYLLESV 76
               TC+   +SV
Sbjct: 786 S---TCSSGEDSV 795

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91286|FGFR2_PLEWA Fibroblast growth factor receptor 2 OS=Pleurodeles waltl GN=FGFR2 PE=2 SV=1

 Score = 58.5 bits (140), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/73 (46%), Positives = 41/73 (56%), Gaps = 8/73 (10%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +M DCW  V S+RP F QLV  LDRILT T NE    EYL+L  PL    PS  D   
Sbjct: 730 YTMMTDCWRAVPSQRPTFKQLVEDLDRILTQTTNE----EYLDLNNPLEPYSPSYPDT-- 783

Query: 64  DDEETCAYLLESV 76
               +C++  +SV
Sbjct: 784 --RSSCSFGDDSV 794

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

Pleurodeles waltl (taxid: 8319)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	202
242005162	887	glutamate receptor, putative [Pediculus	0.589	0.134	0.655	2e-45
328711396	966	PREDICTED: glutamate receptor, ionotropi	0.589	0.123	0.663	3e-45
189234151	945	PREDICTED: similar to GA13857-PA [Tribol	0.589	0.125	0.546	2e-36
270002542	897	hypothetical protein TcasGA2_TC004850 [T	0.589	0.132	0.546	2e-36
379070092	923	putative ionotropic receptor IR25a [Cydi	0.594	0.130	0.590	9e-36
357630725	921	hypothetical protein KGM_04141 [Danaus p	0.569	0.124	0.598	4e-35
399163347	904	ionotropic receptor [Locusta migratoria]	0.584	0.130	0.546	9e-32
21358761	936	ionotropic glutamate receptor subunit [H	0.653	0.141	0.507	3e-31
195147686	949	GL18750 [Drosophila persimilis] gi|19410	0.584	0.124	0.553	4e-31
194856275	921	GG24350 [Drosophila erecta] gi|190660580	0.584	0.128	0.553	4e-31

>gi|242005162|ref|XP_002423441.1| glutamate receptor, putative [Pediculus humanus corporis] gi|212506519|gb|EEB10703.1| glutamate receptor, putative [Pediculus humanus corporis]

 Score =  187 bits (476), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 78/119 (65%), Positives = 106/119 (89%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           NLD E  KYLI + PPGD++PEV+R+++L QNI++A ILFDDSF+ DHKYKSLLQN+PTR
Sbjct: 91  NLDKEDEKYLIHIMPPGDLIPEVVRSLVLAQNISNAAILFDDSFVMDHKYKSLLQNVPTR 150

Query: 141 HIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT 199
           H+I+PVE+S+++K+QL +  DLD+VN+FILGR+ TIKM+LD AN+NK+FG+K++WHAIT
Sbjct: 151 HVISPVENSKTIKKQLTKMIDLDVVNFFILGRMSTIKMVLDHANINKYFGKKYSWHAIT 209

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328711396|ref|XP_001945524.2| PREDICTED: glutamate receptor, ionotropic kainate 4-like [Acyrthosiphon pisum]

 Score =  187 bits (474), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 79/119 (66%), Positives = 103/119 (86%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           NLDGEQ KYLIQ++PP D++PE++R+I++ QNIT+AGI+FDD+F+ DHKYKSLLQNIPTR
Sbjct: 170 NLDGEQQKYLIQISPPADLIPEIVRSIVVAQNITNAGIMFDDTFVMDHKYKSLLQNIPTR 229

Query: 141 HIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT 199
           HIIA ++D+ S+K  L RF+D+DIVN+F+LG+L  IK +LD AN NK FGRK+AWH IT
Sbjct: 230 HIIAAIDDTTSIKLHLTRFRDVDIVNFFVLGKLSIIKSVLDHANSNKLFGRKYAWHVIT 288

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189234151|ref|XP_971258.2| PREDICTED: similar to GA13857-PA [Tribolium castaneum]

 Score =  157 bits (397), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 65/119 (54%), Positives = 96/119 (80%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           N+D  + +YL+Q++PP D++PE+IR+++L +N+T+A ILFDDSF+ DHKYKSLLQN+ TR
Sbjct: 170 NIDENEKEYLVQISPPADVIPEIIRSLVLSKNVTNAAILFDDSFVMDHKYKSLLQNVATR 229

Query: 141 HIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT 199
           H+IAP++++  +  QL + + LDIVN+FILG  + IK +LD+A+   FF RKF+WHAIT
Sbjct: 230 HVIAPIKEADKIGDQLRQLRKLDIVNFFILGSFENIKRVLDAADSVGFFNRKFSWHAIT 288

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270002542|gb|EEZ98989.1| hypothetical protein TcasGA2_TC004850 [Tribolium castaneum]

 Score =  157 bits (397), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 65/119 (54%), Positives = 96/119 (80%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           N+D  + +YL+Q++PP D++PE+IR+++L +N+T+A ILFDDSF+ DHKYKSLLQN+ TR
Sbjct: 122 NIDENEKEYLVQISPPADVIPEIIRSLVLSKNVTNAAILFDDSFVMDHKYKSLLQNVATR 181

Query: 141 HIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT 199
           H+IAP++++  +  QL + + LDIVN+FILG  + IK +LD+A+   FF RKF+WHAIT
Sbjct: 182 HVIAPIKEADKIGDQLRQLRKLDIVNFFILGSFENIKRVLDAADSVGFFNRKFSWHAIT 240

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|379070092|gb|AFC91757.1| putative ionotropic receptor IR25a [Cydia pomonella]

 Score =  155 bits (392), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 72/122 (59%), Positives = 96/122 (78%), Gaps = 2/122 (1%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           NLD  Q K+L+QV PP DILPE IRAI+  Q+IT+A I+FD+ F+ DHKYKSLLQNIPTR
Sbjct: 134 NLDANQTKFLLQVMPPADILPESIRAIVTKQDITNAAIIFDEFFVMDHKYKSLLQNIPTR 193

Query: 141 HIIAPVE--DSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI 198
           H+I PV+  +   +K QL   ++LDIVN+F++G L+TIK +LD+A+ N++FGRK AW A+
Sbjct: 194 HVITPVKSFNRDEIKTQLRSLRELDIVNFFVVGSLRTIKNVLDAADENQYFGRKTAWFAL 253

Query: 199 TL 200
           TL
Sbjct: 254 TL 255

Source: Cydia pomonella

Species: Cydia pomonella

Genus: Cydia

Family: Tortricidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357630725|gb|EHJ78658.1| hypothetical protein KGM_04141 [Danaus plexippus]

 Score =  153 bits (387), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 70/117 (59%), Positives = 93/117 (79%), Gaps = 2/117 (1%)

Query: 86  QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAP 145
           Q KYL+QV PP DILPE +RAI++ Q+IT+A I+FD+ F+ DHKYKSLLQNIPTRH+I P
Sbjct: 138 QTKYLLQVMPPADILPEAVRAIVMKQDITNAAIIFDEYFVMDHKYKSLLQNIPTRHVITP 197

Query: 146 VE--DSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL 200
           V+      +K QL   ++LDIVN+FI+G L+TIK +LD+AN N++FGRK AW A++L
Sbjct: 198 VKSFSKDDIKTQLRSLRELDIVNFFIVGSLRTIKNVLDAANENQYFGRKTAWFALSL 254

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|399163347|gb|AFP33229.1| ionotropic receptor [Locusta migratoria]

 Score =  142 bits (358), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 65/119 (54%), Positives = 90/119 (75%), Gaps = 1/119 (0%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           N+D +Q KY+IQV PP D +PE IR+    QN+T+AGILFDD+FI DHKYKSLLQN+PTR
Sbjct: 131 NIDKKQDKYMIQVMPPIDTIPEFIRSFCSAQNLTNAGILFDDTFIMDHKYKSLLQNVPTR 190

Query: 141 HIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT 199
           HII  ++  +++  QL  FK  ++ NYFILGR+ T+  +L++A   +F+GR+F W+AIT
Sbjct: 191 HIINEIK-FQNIANQLSTFKQREVFNYFILGRMDTVNKVLEAAADMEFYGRQFGWYAIT 248

Source: Locusta migratoria

Species: Locusta migratoria

Genus: Locusta

Family: Acrididae

Order: Orthoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|21358761|gb|AAM47017.1| ionotropic glutamate receptor subunit [Homarus americanus]

 Score =  140 bits (353), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 68/134 (50%), Positives = 94/134 (70%), Gaps = 2/134 (1%)

Query: 68  TCAYLLESVIR-ISNLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIF 126
           + +Y  E  IR    L   + +YL+Q+ PPGDI+ + IR I+  QNIT+AGI++DD+F+ 
Sbjct: 131 SASYGQEGDIREWRKLTPSEEEYLVQLMPPGDIIVQSIRDIVRTQNITNAGIIYDDTFVM 190

Query: 127 DHKYKSLLQNIPTRHIIAPVEDS-RSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANV 185
           +HKYKSLLQN+P RHI+  VE + + V+RQ  R KD DIVNYF +G   TI  ILD+A  
Sbjct: 191 EHKYKSLLQNLPCRHIMTRVEATEKEVRRQTKRLKDADIVNYFAVGSGDTISRILDAATA 250

Query: 186 NKFFGRKFAWHAIT 199
           N  FGRK+AW+A++
Sbjct: 251 NDMFGRKYAWYALS 264

Source: Homarus americanus

Species: Homarus americanus

Genus: Homarus

Family: Nephropidae

Order: Decapoda

Class: Malacostraca

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195147686|ref|XP_002014810.1| GL18750 [Drosophila persimilis] gi|194106763|gb|EDW28806.1| GL18750 [Drosophila persimilis]

 Score =  140 bits (352), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 67/121 (55%), Positives = 91/121 (75%), Gaps = 3/121 (2%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           +LD  + KYL+QV PPGDI+PEVIR+I+   NIT+A IL+D++F+ DHKYKSLLQNI TR
Sbjct: 147 DLDESKQKYLLQVMPPGDIIPEVIRSIVRRLNITNAAILYDETFVMDHKYKSLLQNIQTR 206

Query: 141 HIIAPV--EDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI 198
           H+I  +  E  R  + Q+ + ++LDI N+FILG LQ+I+M+L+S     +F R FAWHAI
Sbjct: 207 HVITAIAMEGKREREEQIEKLRNLDINNFFILGNLQSIRMVLESVK-PAYFERNFAWHAI 265

Query: 199 T 199
           T
Sbjct: 266 T 266

Source: Drosophila persimilis

Species: Drosophila persimilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194856275|ref|XP_001968713.1| GG24350 [Drosophila erecta] gi|190660580|gb|EDV57772.1| GG24350 [Drosophila erecta]

 Score =  140 bits (352), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 67/121 (55%), Positives = 92/121 (76%), Gaps = 3/121 (2%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
           +LD  + KYL+QV PP DI+PEVIR+I++  NIT+A IL+DDSF+ DHKYKSLLQNI TR
Sbjct: 120 DLDEAKQKYLLQVMPPADIIPEVIRSIVIHLNITNAAILYDDSFVMDHKYKSLLQNIQTR 179

Query: 141 HIIAPV--EDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI 198
           H+I  +  +  R  + Q+ + ++LDI N+FILG LQ+I+M+L+S    ++F R FAWHAI
Sbjct: 180 HVITAIAKDGKREREEQIEKLRNLDINNFFILGTLQSIRMVLESVKP-EYFERNFAWHAI 238

Query: 199 T 199
           T
Sbjct: 239 T 239

Source: Drosophila erecta

Species: Drosophila erecta

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	202
FB|FBgn0031634	934	Ir25a "Ionotropic receptor 25a	0.584	0.126	0.545	2.2e-30
UNIPROTKB|P18461	823	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	2e-08
UNIPROTKB|F1NV76	824	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	2e-08
UNIPROTKB|F1NV77	825	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	2.1e-08
UNIPROTKB|F1NEE9	830	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	2.1e-08
UNIPROTKB|F1PPH0	707	FGFR2 "Fibroblast growth facto	0.242	0.069	0.566	8.2e-08
UNIPROTKB|E7EVR7	707	FGFR2 "Fibroblast growth facto	0.242	0.069	0.566	8.2e-08
UNIPROTKB|P21802	821	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	1e-07
UNIPROTKB|F1PPD8	822	FGFR2 "Fibroblast growth facto	0.242	0.059	0.566	1e-07
UNIPROTKB|F1Q2E3	841	FGFR2 "Fibroblast growth facto	0.242	0.058	0.566	1e-07

FB|FBgn0031634 Ir25a "Ionotropic receptor 25a" [Drosophila melanogaster (taxid:7227)]

 Score = 346 (126.9 bits), Expect = 2.2e-30, P = 2.2e-30
 Identities = 66/121 (54%), Positives = 90/121 (74%)

Query:    81 NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
             +LD  + KYL+QV PP DI+PE IR+I++  NIT+A IL+DDSF+ DHKYKSLLQNI TR
Sbjct:   133 DLDEAKQKYLLQVMPPADIIPEAIRSIVIHMNITNAAILYDDSFVMDHKYKSLLQNIQTR 192

Query:   141 HIIAPV--EDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI 198
             H+I  +  +  R  + Q+ + ++LDI N+FILG LQ+I+M+L+S     +F R FAWHAI
Sbjct:   193 HVITAIAKDGKREREEQIEKLRNLDINNFFILGTLQSIRMVLESVKP-AYFERNFAWHAI 251

Query:   199 T 199
             T
Sbjct:   252 T 252

GO:0005234 "extracellular-glutamate-gated ion channel activity" evidence=IEA;ISS

GO:0006811 "ion transport" evidence=IEA

GO:0004970 "ionotropic glutamate receptor activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0050907 "detection of chemical stimulus involved in sensory perception" evidence=IEP

GO:0015276 "ligand-gated ion channel activity" evidence=ISM

GO:0016021 "integral to membrane" evidence=ISM

GO:0071683 "sensory dendrite" evidence=IDA

GO:0005929 "cilium" evidence=IDA

GO:0007608 "sensory perception of smell" evidence=IMP

UNIPROTKB|P18461 FGFR2 "Fibroblast growth factor receptor 2" [Gallus gallus (taxid:9031)]

 Score = 140 (54.3 bits), Expect = 2.0e-08, P = 2.0e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   735 YMMMRDCWQAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSGPLEQYSP 783

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

UNIPROTKB|F1NV76 FGFR2 "Fibroblast growth factor receptor" [Gallus gallus (taxid:9031)]

 Score = 140 (54.3 bits), Expect = 2.0e-08, P = 2.0e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   736 YMMMRDCWQAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSGPLEQYSP 784

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NV77 FGFR2 "Fibroblast growth factor receptor" [Gallus gallus (taxid:9031)]

 Score = 140 (54.3 bits), Expect = 2.1e-08, P = 2.1e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   737 YMMMRDCWQAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSGPLEQYSP 785

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NEE9 FGFR2 "Fibroblast growth factor receptor" [Gallus gallus (taxid:9031)]

 Score = 140 (54.3 bits), Expect = 2.1e-08, P = 2.1e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   742 YMMMRDCWQAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSGPLEQYSP 790

GO:0005524 "ATP binding" evidence=IEA

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0001525 "angiogenesis" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0002053 "positive regulation of mesenchymal cell proliferation" evidence=IEA

GO:0003148 "outflow tract septum morphogenesis" evidence=IEA

GO:0003149 "membranous septum morphogenesis" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0007528 "neuromuscular junction development" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0008589 "regulation of smoothened signaling pathway" evidence=IEA

GO:0009791 "post-embryonic development" evidence=IEA

GO:0009880 "embryonic pattern specification" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0010453 "regulation of cell fate commitment" evidence=IEA

GO:0010518 "positive regulation of phospholipase activity" evidence=IEA

GO:0017134 "fibroblast growth factor binding" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0030282 "bone mineralization" evidence=IEA

GO:0030901 "midbrain development" evidence=IEA

GO:0030916 "otic vesicle formation" evidence=IEA

GO:0031012 "extracellular matrix" evidence=IEA

GO:0031069 "hair follicle morphogenesis" evidence=IEA

GO:0032808 "lacrimal gland development" evidence=IEA

GO:0035264 "multicellular organism growth" evidence=IEA

GO:0035265 "organ growth" evidence=IEA

GO:0040014 "regulation of multicellular organism growth" evidence=IEA

GO:0040036 "regulation of fibroblast growth factor receptor signaling pathway" evidence=IEA

GO:0042476 "odontogenesis" evidence=IEA

GO:0042803 "protein homodimerization activity" evidence=IEA

GO:0045165 "cell fate commitment" evidence=IEA

GO:0045839 "negative regulation of mitosis" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0048286 "lung alveolus development" evidence=IEA

GO:0048489 "synaptic vesicle transport" evidence=IEA

GO:0048557 "embryonic digestive tract morphogenesis" evidence=IEA

GO:0048755 "branching morphogenesis of a nerve" evidence=IEA

GO:0051150 "regulation of smooth muscle cell differentiation" evidence=IEA

GO:0051781 "positive regulation of cell division" evidence=IEA

GO:0055010 "ventricular cardiac muscle tissue morphogenesis" evidence=IEA

GO:0060045 "positive regulation of cardiac muscle cell proliferation" evidence=IEA

GO:0060174 "limb bud formation" evidence=IEA

GO:0060365 "coronal suture morphogenesis" evidence=IEA

GO:0060449 "bud elongation involved in lung branching" evidence=IEA

GO:0060463 "lung lobe morphogenesis" evidence=IEA

GO:0060484 "lung-associated mesenchyme development" evidence=IEA

GO:0060501 "positive regulation of epithelial cell proliferation involved in lung morphogenesis" evidence=IEA

GO:0060523 "prostate epithelial cord elongation" evidence=IEA

GO:0060527 "prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis" evidence=IEA

GO:0060529 "squamous basal epithelial stem cell differentiation involved in prostate gland acinus development" evidence=IEA

GO:0060595 "fibroblast growth factor receptor signaling pathway involved in mammary gland specification" evidence=IEA

GO:0060601 "lateral sprouting from an epithelium" evidence=IEA

GO:0060615 "mammary gland bud formation" evidence=IEA

GO:0060664 "epithelial cell proliferation involved in salivary gland morphogenesis" evidence=IEA

GO:0060667 "branch elongation involved in salivary gland morphogenesis" evidence=IEA

GO:0060670 "branching involved in labyrinthine layer morphogenesis" evidence=IEA

GO:0060687 "regulation of branching involved in prostate gland morphogenesis" evidence=IEA

GO:0060915 "mesenchymal cell differentiation involved in lung development" evidence=IEA

GO:0060916 "mesenchymal cell proliferation involved in lung development" evidence=IEA

GO:0061031 "endodermal digestive tract morphogenesis" evidence=IEA

GO:0070307 "lens fiber cell development" evidence=IEA

GO:0070374 "positive regulation of ERK1 and ERK2 cascade" evidence=IEA

GO:0090263 "positive regulation of canonical Wnt receptor signaling pathway" evidence=IEA

UNIPROTKB|F1PPH0 FGFR2 "Fibroblast growth factor receptor" [Canis lupus familiaris (taxid:9615)]

 Score = 138 (53.6 bits), Expect = 8.2e-08, P = 8.2e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   619 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSP 667

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|E7EVR7 FGFR2 "Fibroblast growth factor receptor" [Homo sapiens (taxid:9606)]

 Score = 138 (53.6 bits), Expect = 8.2e-08, P = 8.2e-08
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   619 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSP 667

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|P21802 FGFR2 "Fibroblast growth factor receptor 2" [Homo sapiens (taxid:9606)]

 Score = 138 (53.6 bits), Expect = 1.0e-07, P = 1.0e-07
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   733 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSP 781

GO:0005524 "ATP binding" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0008201 "heparin binding" evidence=IEA

GO:0007528 "neuromuscular junction development" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0045839 "negative regulation of mitosis" evidence=IEA

GO:0048489 "synaptic vesicle transport" evidence=IEA

GO:0060365 "coronal suture morphogenesis" evidence=IEA

GO:0061031 "endodermal digestive tract morphogenesis" evidence=IEA

GO:0070307 "lens fiber cell development" evidence=IEA

GO:0005576 "extracellular region" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IGI;IDA;NAS

GO:0004713 "protein tyrosine kinase activity" evidence=NAS

GO:0016021 "integral to membrane" evidence=NAS

GO:0009986 "cell surface" evidence=IDA

GO:0048568 "embryonic organ development" evidence=ISS

GO:0048608 "reproductive structure development" evidence=ISS

GO:0048730 "epidermis morphogenesis" evidence=ISS

GO:0048755 "branching morphogenesis of a nerve" evidence=ISS

GO:0048762 "mesenchymal cell differentiation" evidence=ISS

GO:0050679 "positive regulation of epithelial cell proliferation" evidence=ISS

GO:0051150 "regulation of smooth muscle cell differentiation" evidence=ISS

GO:0051781 "positive regulation of cell division" evidence=ISS

GO:0055010 "ventricular cardiac muscle tissue morphogenesis" evidence=ISS

GO:0060045 "positive regulation of cardiac muscle cell proliferation" evidence=ISS

GO:0060174 "limb bud formation" evidence=ISS

GO:0060348 "bone development" evidence=ISS

GO:0060349 "bone morphogenesis" evidence=ISS

GO:0060442 "branching involved in prostate gland morphogenesis" evidence=ISS

GO:0060445 "branching involved in salivary gland morphogenesis" evidence=ISS

GO:0060449 "bud elongation involved in lung branching" evidence=ISS

GO:0060463 "lung lobe morphogenesis" evidence=ISS

GO:0060484 "lung-associated mesenchyme development" evidence=ISS

GO:0060501 "positive regulation of epithelial cell proliferation involved in lung morphogenesis" evidence=ISS

GO:0060512 "prostate gland morphogenesis" evidence=ISS

GO:0060523 "prostate epithelial cord elongation" evidence=ISS

GO:0060527 "prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis" evidence=ISS

GO:0060529 "squamous basal epithelial stem cell differentiation involved in prostate gland acinus development" evidence=ISS

GO:0060595 "fibroblast growth factor receptor signaling pathway involved in mammary gland specification" evidence=ISS

GO:0060601 "lateral sprouting from an epithelium" evidence=ISS

GO:0060615 "mammary gland bud formation" evidence=ISS

GO:0060664 "epithelial cell proliferation involved in salivary gland morphogenesis" evidence=ISS

GO:0060667 "branch elongation involved in salivary gland morphogenesis" evidence=ISS

GO:0060670 "branching involved in labyrinthine layer morphogenesis" evidence=ISS

GO:0060687 "regulation of branching involved in prostate gland morphogenesis" evidence=ISS

GO:0060688 "regulation of morphogenesis of a branching structure" evidence=ISS

GO:0060915 "mesenchymal cell differentiation involved in lung development" evidence=ISS

GO:0060916 "mesenchymal cell proliferation involved in lung development" evidence=ISS

GO:0070372 "regulation of ERK1 and ERK2 cascade" evidence=ISS

GO:0070374 "positive regulation of ERK1 and ERK2 cascade" evidence=ISS

GO:0090263 "positive regulation of canonical Wnt receptor signaling pathway" evidence=ISS

GO:0021769 "orbitofrontal cortex development" evidence=ISS

GO:0021847 "ventricular zone neuroblast division" evidence=ISS

GO:0021860 "pyramidal neuron development" evidence=ISS

GO:0045787 "positive regulation of cell cycle" evidence=ISS

GO:0060076 "excitatory synapse" evidence=ISS

GO:0035602 "fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow" evidence=ISS

GO:0035603 "fibroblast growth factor receptor signaling pathway involved in hemopoiesis" evidence=ISS

GO:0035604 "fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow" evidence=ISS

GO:0035607 "fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development" evidence=ISS

GO:0031012 "extracellular matrix" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0001525 "angiogenesis" evidence=ISS

GO:0001657 "ureteric bud development" evidence=ISS

GO:0001701 "in utero embryonic development" evidence=ISS

GO:0002053 "positive regulation of mesenchymal cell proliferation" evidence=ISS

GO:0003148 "outflow tract septum morphogenesis" evidence=ISS

GO:0003149 "membranous septum morphogenesis" evidence=ISS

GO:0007267 "cell-cell signaling" evidence=ISS

GO:0007409 "axonogenesis" evidence=ISS

GO:0008589 "regulation of smoothened signaling pathway" evidence=ISS

GO:0032808 "lacrimal gland development" evidence=ISS

GO:0035264 "multicellular organism growth" evidence=ISS

GO:0035265 "organ growth" evidence=ISS

GO:0040014 "regulation of multicellular organism growth" evidence=ISS

GO:0040036 "regulation of fibroblast growth factor receptor signaling pathway" evidence=ISS

GO:0042472 "inner ear morphogenesis" evidence=ISS

GO:0042476 "odontogenesis" evidence=ISS

GO:0045165 "cell fate commitment" evidence=ISS

GO:0048286 "lung alveolus development" evidence=ISS

GO:0048557 "embryonic digestive tract morphogenesis" evidence=ISS

GO:0048562 "embryonic organ morphogenesis" evidence=ISS

GO:0048565 "digestive tract development" evidence=ISS

GO:0016020 "membrane" evidence=NAS

GO:0005938 "cell cortex" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0017134 "fibroblast growth factor binding" evidence=IDA;IPI

GO:0008284 "positive regulation of cell proliferation" evidence=IGI;IMP;IDA

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=IGI;IDA;TAS;IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IDA

GO:0043410 "positive regulation of MAPK cascade" evidence=IMP

GO:0005887 "integral to plasma membrane" evidence=IDA

GO:0010518 "positive regulation of phospholipase activity" evidence=IMP

GO:0042803 "protein homodimerization activity" evidence=IPI

GO:0033688 "regulation of osteoblast proliferation" evidence=TAS

GO:0048705 "skeletal system morphogenesis" evidence=TAS

GO:0045667 "regulation of osteoblast differentiation" evidence=TAS

GO:0009791 "post-embryonic development" evidence=ISS

GO:0009880 "embryonic pattern specification" evidence=ISS

GO:0009887 "organ morphogenesis" evidence=ISS

GO:0010453 "regulation of cell fate commitment" evidence=ISS

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISS

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISS

GO:0016331 "morphogenesis of embryonic epithelium" evidence=ISS

GO:0022612 "gland morphogenesis" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0030282 "bone mineralization" evidence=ISS

GO:0030324 "lung development" evidence=ISS

GO:0030855 "epithelial cell differentiation" evidence=ISS

GO:0030901 "midbrain development" evidence=ISS

GO:0030916 "otic vesicle formation" evidence=ISS

GO:0031069 "hair follicle morphogenesis" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA;TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0048701 "embryonic cranial skeleton morphogenesis" evidence=IMP

UNIPROTKB|F1PPD8 FGFR2 "Fibroblast growth factor receptor" [Canis lupus familiaris (taxid:9615)]

 Score = 138 (53.6 bits), Expect = 1.0e-07, P = 1.0e-07
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   734 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSP 782

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|F1Q2E3 FGFR2 "Fibroblast growth factor receptor" [Canis lupus familiaris (taxid:9615)]

 Score = 138 (53.6 bits), Expect = 1.0e-07, P = 1.0e-07
 Identities = 30/53 (56%), Positives = 34/53 (64%)

Query:     4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPP 56
             Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL    P
Sbjct:   753 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPLEQYSP 801

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	202
cd06383	368	cd06383, PBP1_iGluR_AMPA_Like, N-terminal leucine/	8e-38
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-05
cd06351	328	cd06351, PBP1_iGluR_N_LIVBP_like, N-terminal leuci	4e-05
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-04
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-04
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-04
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	0.001
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.001
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.002
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.003
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	0.004

>gnl|CDD|107378 cd06383, PBP1_iGluR_AMPA_Like, N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors

 Score =  133 bits (337), Expect = 8e-38
 Identities = 56/121 (46%), Positives = 73/121 (60%), Gaps = 2/121 (1%)

Query: 81  NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
                +  YLIQ+ PP D + E IR I+   NIT+A IL+DD F+ DHKYKSLLQN PTR
Sbjct: 101 QEGDLEQPYLIQLMPPADDIVEAIRDIVSYYNITNAAILYDDDFVMDHKYKSLLQNWPTR 160

Query: 141 HIIAPVEDSRS-VKRQLFRFKDLDIVNYFILGRL-QTIKMILDSANVNKFFGRKFAWHAI 198
           H+I  +      V+ Q+ R ++LDI N FILG   + I+ +LD A    F GRK+AW   
Sbjct: 161 HVITIINSIIDEVREQIKRLRNLDIKNIFILGSTEEIIRYVLDQALAEGFMGRKYAWFLG 220

Query: 199 T 199
            
Sbjct: 221 N 221

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excitatory synaptic current. Length = 368

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 30/67 (44%), Positives = 37/67 (55%), Gaps = 9/67 (13%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED--- 60
           Y +MR+CW  V S+RP F QLV  LDR+LTVT+ +    EYL+L  P     P   D   
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD----EYLDLSVPFEQYSPGCPDSPS 321

Query: 61  --ESNDD 65
              S DD
Sbjct: 322 SCSSGDD 328

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 22/35 (62%), Positives = 25/35 (71%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  + S RP F QLV  LDRILT+T NE
Sbjct: 269 YMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 21/35 (60%), Positives = 26/35 (74%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRIL +T+N+
Sbjct: 272 YMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.8 bits (116), Expect = 4e-07
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 5/54 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPS 57
           Y LMR+CW  V ++RP F QLV  LD++L       + +EYL+L  P     PS
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAA-----VSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.2 bits (115), Expect = 6e-07
 Identities = 20/30 (66%), Positives = 22/30 (73%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y LMRDCW  V S+RP F QLV  LDR+LT
Sbjct: 264 YHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 15/29 (51%), Positives = 21/29 (72%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y+LM DCW    +ERP F Q+VS LD+++
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|107346 cd06351, PBP1_iGluR_N_LIVBP_like, N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs)

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 19/155 (12%)

Query: 55  PPSSEDESNDDEETCAYLLESVIRIS-----NLDGEQMKYLIQVNPPGDILPEVIRAIIL 109
            P+S + ++  +  C  L    I IS       D E+    +Q+ P  + L + +  ++ 
Sbjct: 69  GPTSSESASAVQSICDALEIPHISISGGSEGLSDKEESSTTLQLYPSLEDLADALLDLLE 128

Query: 110 MQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAP-------VEDSRSVKRQLFR-FKD 161
             N T   I++D          S LQ +     I         ++      RQL +  K 
Sbjct: 129 YYNWTKFAIIYDSDE-----GLSRLQELLDESGIKGIQVTVRRLDLDDDNYRQLLKELKR 183

Query: 162 LDIVNYFILG-RLQTIKMILDSANVNKFFGRKFAW 195
            +     +     +  K IL+ A      G  + W
Sbjct: 184 SESRRIILDCSSEEEAKEILEQAVELGMMGYGYHW 218

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs). While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors characterized by their response to glutamate agonists: N-methyl-aspartate (NMDA) and non-NMDA receptors. NMDA receptors have intrinsically slow kinetics, are highly permeable to Ca2+, and are blocked by extracellular Mg2+ in a voltage-dependent manner. On the other hand, non-NMDA receptors have faster kinetics, are weakly permeable to Ca2+, and are not blocked by extracellular Mg2+. While non-NMDA receptors typically mediate excitatory synaptic responses at resting membrane potentials, NMDA receptors contribute to several forms of synaptic plasticity and are suggested to play an important role in the development of synaptic pathways. Length = 328

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 12/26 (46%), Positives = 16/26 (61%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLD 29
           YELM  CW     +RP F +LV +L+
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 39.4 bits (93), Expect = 5e-04
 Identities = 13/25 (52%), Positives = 16/25 (64%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKL 28
           YELM  CW+Y   +RP F +LV  L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 39.4 bits (93), Expect = 6e-04
 Identities = 11/25 (44%), Positives = 15/25 (60%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKL 28
           Y+LM  CW+    +RP F +LV  L
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 14/29 (48%), Positives = 19/29 (65%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y LM  CW+Y  S+RP F +L ++L  IL
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 38.3 bits (90), Expect = 0.001
 Identities = 11/25 (44%), Positives = 15/25 (60%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKL 28
           Y+LM  CW+    +RP F +LV  L
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 38.3 bits (89), Expect = 0.001
 Identities = 14/29 (48%), Positives = 22/29 (75%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           ++LM DCW    +ERP+F Q+VS LD+++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 37.7 bits (88), Expect = 0.002
 Identities = 13/27 (48%), Positives = 16/27 (59%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDR 30
            ELMR CW Y    RP F+++VS L  
Sbjct: 251 LELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 37.0 bits (86), Expect = 0.003
 Identities = 12/28 (42%), Positives = 18/28 (64%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRI 31
           Y++M+DCW    ++RP F QL  +L  I
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 37.0 bits (86), Expect = 0.004
 Identities = 11/29 (37%), Positives = 17/29 (58%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y+LM+ CW     +RP F  L+  +DR+ 
Sbjct: 256 YDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	202
KOG0196|consensus	996		99.39
cd06383	368	PBP1_iGluR_AMPA_Like N-terminal leucine/isoleucine	98.71
KOG4278|consensus	1157		98.02
KOG0200|consensus	609		97.98
KOG1095|consensus	1025		97.79
KOG4257|consensus	974		97.6
KOG1025|consensus	1177		97.25
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	97.03
KOG0192|consensus	362		97.01
KOG0199|consensus	1039		96.88
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	96.84
cd06351	328	PBP1_iGluR_N_LIVBP_like N-terminal leucine/isoleuc	96.41
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	96.4
cd06393	384	PBP1_iGluR_Kainate_GluR5_7 N-terminal leucine/isol	96.37
cd06387	372	PBP1_iGluR_AMPA_GluR3 N-terminal leucine/isoleucin	96.29
cd06390	364	PBP1_iGluR_AMPA_GluR1 N-terminal leucine/isoleucin	95.51
PF01094	348	ANF_receptor: Receptor family ligand binding regio	95.48
cd06392	400	PBP1_iGluR_delta_1 N-terminal leucine/isoleucine/v	95.28
KOG4721|consensus	904		95.11
cd06389	370	PBP1_iGluR_AMPA_GluR2 N-terminal leucine/isoleucin	94.29
cd06379	377	PBP1_iGluR_NMDA_NR1 N-terminal leucine/isoleucine/	94.18
cd06380	382	PBP1_iGluR_AMPA N-terminal leucine/isoleucine/vali	94.08
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	94.07
cd06381	363	PBP1_iGluR_delta_like N-terminal leucine/isoleucin	93.84
KOG0194|consensus	474		93.7
cd06388	371	PBP1_iGluR_AMPA_GluR4 N-terminal leucine/isoleucin	93.46
cd06269	298	PBP1_glutamate_receptors_like Family C G-protein c	93.39
cd06394	333	PBP1_iGluR_Kainate_KA1_2 N-terminal leucine/isoleu	93.32
cd06386	387	PBP1_NPR_C_like Ligand-binding domain of type C na	93.19
cd06391	400	PBP1_iGluR_delta_2 N-terminal leucine/isoleucine/v	93.18
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	93.16
cd06378	362	PBP1_iGluR_NMDA_NR2 N-terminal leucine/isoleucine/	92.4
KOG1023|consensus	484		92.39
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	92.19
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	91.82
cd06385	405	PBP1_NPR_A Ligand-binding domain of type A natriur	91.18
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	91.16
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	90.4
cd06368	324	PBP1_iGluR_non_NMDA_like N-terminal leucine/isoleu	90.12
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	90.07
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	89.69
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	89.57
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	89.5
cd06367	362	PBP1_iGluR_NMDA N-terminal leucine/isoleucine/vali	88.82
cd06382	327	PBP1_iGluR_Kainate N-terminal leucine/isoleucine/v	88.82
cd06373	396	PBP1_NPR_like Ligand binding domain of natriuretic	87.96
cd06384	399	PBP1_NPR_B Ligand-binding domain of type B natriur	87.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	87.27
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	87.27
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	86.85
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	86.56
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	86.56
PTZ00283	496	serine/threonine protein kinase; Provisional	86.54
cd06376	463	PBP1_mGluR_groupIII Ligand-binding domain of the g	86.53
cd06366	350	PBP1_GABAb_receptor Ligand-binding domain of GABAb	85.85
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	85.63
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	84.77
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	84.18
PTZ00267	478	NIMA-related protein kinase; Provisional	83.77
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	83.35
cd06352	389	PBP1_NPR_GC_like Ligand-binding domain of membrane	82.51
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	81.49
cd04509	299	PBP1_ABC_transporter_GCPR_C_like Family C of G-pro	80.91

>KOG0196|consensus

Probab=99.39  E-value=3.6e-13  Score=132.98  Aligned_cols=104  Identities=30%  Similarity=0.425  Sum_probs=86.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhccccc-ccccccCCCCCCCCCCCCCCCCCCchhhHhhhhhhhhhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYL-GQEYLELEAPLLDTPPSSEDESNDDEETCAYLLESVIRIS   80 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~~~~-~~~Yldls~p~~~~sps~~d~~~~~~~t~~~~lesI~~Wr   80 (202)
                      .||+||++||++++.+||+|.||+..|+++++++.+++. ...-...+.++.+.  +.+|..  ...++++|+++|    
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~--~~~~~~--~f~sv~~WL~aI----  933 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDR--SGSDFT--PFRSVGDWLEAI----  933 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCC--CCCCCc--ccCCHHHHHHHh----
Confidence            699999999999999999999999999999999998776 44444455565553  333433  448999999999    


Q ss_pred             ccCcccccceEeeCCCCCChHHHHHHH----HHHhcCCcce
Q psy12232         81 NLDGEQMKYLIQVNPPGDILPEVIRAI----ILMQNITDAG  117 (202)
Q Consensus        81 ~l~~~~~~YLlqv~pp~~~~pe~vr~~----~~~~nit~Ag  117 (202)
                          .+.+|..+|+.+|....+.|.++    +.++|||.+|
T Consensus       934 ----km~rY~~~F~~ag~~s~~~V~q~s~eDl~~~Gitl~G  970 (996)
T KOG0196|consen  934 ----KMGRYKEHFAAAGYTSFEDVAQMSAEDLLRLGITLAG  970 (996)
T ss_pred             ----hhhHHHHHHHhcCcccHHHHHhhhHHHHHhhceeecc
Confidence                49999999999999999999998    5899999754

>cd06383 PBP1_iGluR_AMPA_Like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors

Probab=98.71  E-value=2.7e-08  Score=90.43  Aligned_cols=116  Identities=48%  Similarity=0.784  Sum_probs=105.4

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhccCCccccccCCC-cchhHHHHHhhcccCce
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVE-DSRSVKRQLFRFKDLDI  164 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~~p~rh~~~~~~-~~~~~~~~~~~~~~~d~  164 (202)
                      +.+|.++..|+......++.+++...|-+..+++|++.+.+.|.+..++++.+.+|...... ...++..+|+++++.+.
T Consensus       106 ~~p~~ir~~Ps~~~~~~Ai~dlI~~f~W~~v~iIYddd~gl~~~l~~~l~~~~~~~~~~v~~~~~~~~~~~Lk~lk~~~~  185 (368)
T cd06383         106 EQPYLIQLMPPADDIVEAIRDIVSYYNITNAAILYDDDFVMDHKYKSLLQNWPTRHVITIINSIIDEVREQIKRLRNLDI  185 (368)
T ss_pred             cCceEEEEeCChHHHHHHHHHHHHHCCCcEEEEEEEcCchhhHHHHHHHHhHHhcCCEEEEeccchhHHHHHHHHHhCCC
Confidence            56788999999999999999999999999999999999999999999999988888776543 35678899999999999


Q ss_pred             eeeeeecch-hhHHHHHhhhhhhhcccccceeEEeecc
Q psy12232        165 VNYFILGRL-QTIKMILDSANVNKFFGRKFAWHAITLV  201 (202)
Q Consensus       165 ~n~f~~g~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~  201 (202)
                      .++||+++. +.+..+|+.|...++.|++|.|+..+.|
T Consensus       186 ~rIIi~~s~~~~~~~il~qA~~lgm~~~~y~wilt~ld  223 (368)
T cd06383         186 KNIFILGSTEEIIRYVLDQALAEGFMGRKYAWFLGNPD  223 (368)
T ss_pred             eEEEEEeCCHHHHHHHHHHHHHcCCcCCceEEEEcCCC
Confidence            999999997 9999999999999999999999998765

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of uncharacterized AMPA-like receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excitatory synaptic current.

>KOG4278|consensus

Probab=98.02  E-value=3.6e-06  Score=83.20  Aligned_cols=35  Identities=31%  Similarity=0.868  Sum_probs=32.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+|+||+.||+|+|.+||+|++|...|+.|+++.+
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            58999999999999999999999999999998654

>KOG0200|consensus

Probab=97.98  E-value=6.1e-06  Score=79.99  Aligned_cols=47  Identities=30%  Similarity=0.567  Sum_probs=37.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcccccccccccCCCCCCCCC
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTP   55 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~~~~~~~Yldls~p~~~~s   55 (202)
                      ++|++|+.||+.+|.+||+|.+++..|+.++..  .     .|+++......+.
T Consensus       550 eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~--~-----~~~~~~~~~~~~~  596 (609)
T KOG0200|consen  550 EIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD--E-----LYLDVEAFEQSKL  596 (609)
T ss_pred             HHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH--h-----hhhhhhccccccc
Confidence            689999999999999999999999999997665  1     4666665444433

>KOG1095|consensus

Probab=97.79  E-value=2.4e-05  Score=80.32  Aligned_cols=46  Identities=28%  Similarity=0.478  Sum_probs=37.5

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcccccccccccCCCCC
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL   51 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~~~~~~~Yldls~p~   51 (202)
                      .||+||++||+.+|.+||+|..|++++..++.....    .+|.......
T Consensus       932 ~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~----~~~~~~~a~~  977 (1025)
T KOG1095|consen  932 KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG----TIYGPLPADY  977 (1025)
T ss_pred             HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc----Cccccccccc
Confidence            589999999999999999999999999988886654    4555544433

>KOG4257|consensus

Probab=97.60  E-value=4.6e-05  Score=75.41  Aligned_cols=33  Identities=36%  Similarity=0.831  Sum_probs=31.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTV   34 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~   34 (202)
                      .||.||.+||.++|.+||+|.+|+..|..+++.
T Consensus       620 ~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            489999999999999999999999999999884

>KOG1025|consensus

Probab=97.25  E-value=0.0003  Score=71.42  Aligned_cols=37  Identities=27%  Similarity=0.596  Sum_probs=34.8

Q ss_pred             ChHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          1 MSSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         1 ~~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      +++|.+|.+||..++..||+|.++...+.++.+++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            3799999999999999999999999999999999865

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=97.03  E-value=0.0005  Score=59.34  Aligned_cols=36  Identities=25%  Similarity=0.599  Sum_probs=32.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+++++.+||..+|.+||+|.+++..+..+...+..
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence            478999999999999999999999999988877653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0192|consensus

Probab=97.01  E-value=0.00064  Score=62.64  Aligned_cols=35  Identities=34%  Similarity=0.717  Sum_probs=31.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+-.||.+||+.+|..||+|.+|+..|+.+.....
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            36689999999999999999999999998887544

>KOG0199|consensus

Probab=96.88  E-value=0.00055  Score=68.70  Aligned_cols=28  Identities=29%  Similarity=0.792  Sum_probs=25.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLD   29 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le   29 (202)
                      +||++|++||..+|.+||||..|++.+-
T Consensus       343 dIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  343 DIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHHHHHHHhccCCccccccHHHHHHhHH
Confidence            6999999999999999999999996654

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=96.84  E-value=0.0017  Score=56.62  Aligned_cols=52  Identities=50%  Similarity=0.930  Sum_probs=40.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcccccccccccCCCCCCCCCCC
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPS   57 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~~~~~~~Yldls~p~~~~sps   57 (202)
                      .+.+++.+||+.+|.+||++.+|+..|+++......    ..|..++.+..++++-
T Consensus       264 ~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~----~~~~~~~~~~~~~~~~  315 (334)
T cd05100         264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST----DEYLDLSVPFEQYSPG  315 (334)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC----CCeeeeeeeeeecCCC
Confidence            478999999999999999999999999999865543    3455556555554443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06351 PBP1_iGluR_N_LIVBP_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs)

Probab=96.41  E-value=0.011  Score=50.49  Aligned_cols=115  Identities=17%  Similarity=0.212  Sum_probs=84.9

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhccCCc--ccccc-CCC-cchhHHHHHhhccc
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPT--RHIIA-PVE-DSRSVKRQLFRFKD  161 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~~p~--rh~~~-~~~-~~~~~~~~~~~~~~  161 (202)
                      ..+|.+++.|+....-+++..++...+....+++|++.-. .-....+++..-.  .++.. .+. +.++...++++++.
T Consensus       105 ~~~~~~~~~p~~~~~~~a~~~~l~~~~w~~v~iiy~~~~~-~~~l~~~~~~~~~~~~~v~~~~~~~~~~~~~~~l~~l~~  183 (328)
T cd06351         105 ESSTTLQLYPSLEDLADALLDLLEYYNWTKFAIIYDSDEG-LSRLQELLDESGIKGIQVTVRRLDLDDDNYRQLLKELKR  183 (328)
T ss_pred             cccceEEecCCHHHHHHHHHHHHHHcCCcEEEEEEeCchH-HHHHHHHHHhhcccCceEEEEEecCCchhHHHHHHHHhh
Confidence            5678899999888888888888888999999999987762 2223344442111  11111 111 12358889999998


Q ss_pred             Cceeeeeeecch-hhHHHHHhhhhhhhcccccceeEEeecc
Q psy12232        162 LDIVNYFILGRL-QTIKMILDSANVNKFFGRKFAWHAITLV  201 (202)
Q Consensus       162 ~d~~n~f~~g~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~  201 (202)
                      ....+++|++.. +.+..+|+.|....+.+..|-|...+.+
T Consensus       184 ~~~~~vil~~~~~~~~~~~l~~a~~~gm~~~~~~~i~~~~~  224 (328)
T cd06351         184 SESRRIILDCSSEEEAKEILEQAVELGMMGYGYHWILTNLD  224 (328)
T ss_pred             cccceEEEECCcHHHHHHHHHHHHHhccccCCcEEEEecCC
Confidence            877788998888 9999999999999999999999987654

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NMDA, AMPA, and kainate receptor subtypes of ionotropic glutamate receptors (iGluRs). While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors characterized by their response to glutamate agonists: N-methyl-aspartate (NMDA) and non-NMDA receptors

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=96.40  E-value=0.0042  Score=53.27  Aligned_cols=36  Identities=28%  Similarity=0.610  Sum_probs=31.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+++++.+||..+|.+||++.+++..|..+......
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR  274 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence            468899999999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06393 PBP1_iGluR_Kainate_GluR5_7 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor

Probab=96.37  E-value=0.015  Score=52.44  Aligned_cols=113  Identities=18%  Similarity=0.166  Sum_probs=79.9

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc---cCCccccccCCC-cchhHHHHHhhcccC
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ---NIPTRHIIAPVE-DSRSVKRQLFRFKDL  162 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~---~~p~rh~~~~~~-~~~~~~~~~~~~~~~  162 (202)
                      ..|.+.+.|+......++..++...+....+++|+++..... -+.+.+   .....-...... +..++..||+++|..
T Consensus       113 ~~~~~~~~~~~~~~~~a~~~~~~~~~wk~vaily~~~~g~~~-l~~~~~~~~~~g~~v~~~~~~~~~~d~~~~L~~ik~~  191 (384)
T cd06393         113 DTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYDDSTGLIR-LQELIMAPSRYNIRLKIRQLPTDSDDARPLLKEMKRG  191 (384)
T ss_pred             ceeEEEeccCHHHHHHHHHHHHHHcCCcEEEEEEeCchhHHH-HHHHHHhhhccCceEEEEECCCCchHHHHHHHHHhhc
Confidence            345555555544566777778888899999999997654221 112221   111221111223 357899999999998


Q ss_pred             ceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeec
Q psy12232        163 DIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL  200 (202)
Q Consensus       163 d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  200 (202)
                      .-..+|+.|.......++..|....+.+..|+|..-+.
T Consensus       192 ~~~~iil~~~~~~~~~il~qa~~~gm~~~~~~~~~~~~  229 (384)
T cd06393         192 REFRIIFDCSHQMAAQILKQAMAMGMMTEYYHFIFTTL  229 (384)
T ss_pred             CceEEEEECCHHHHHHHHHHHHHhccccCceEEEEccC
Confidence            88888999999999999999999999999999975443

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR5-7 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels activated

>cd06387 PBP1_iGluR_AMPA_GluR3 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA receptor

Probab=96.29  E-value=0.022  Score=52.37  Aligned_cols=113  Identities=17%  Similarity=0.274  Sum_probs=88.0

Q ss_pred             ccccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc---hhhhhhhc---cCCccccccCCCcchhHHHHHhh
Q psy12232         85 EQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD---HKYKSLLQ---NIPTRHIIAPVEDSRSVKRQLFR  158 (202)
Q Consensus        85 ~~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~---~ky~~ll~---~~p~rh~~~~~~~~~~~~~~~~~  158 (202)
                      ...+|.+++.|+   .-.++..++...+=....++||..+..-   +-++.+-+   .||++.+.. +.+..+....++.
T Consensus        99 ~~~~~~l~l~P~---l~~Ai~diI~~~~Wr~~~~iYd~d~gl~~Lq~L~~~~~~~~~~V~~~~v~~-~~~~~~~~~~l~e  174 (372)
T cd06387          99 ADVQFVIQMRPA---LKGAILSLLAHYKWEKFVYLYDTERGFSILQAIMEAAVQNNWQVTARSVGN-IKDVQEFRRIIEE  174 (372)
T ss_pred             CCCceEEEEChh---HHHHHHHHHHhcCCCEEEEEecCchhHHHHHHHHHhhccCCceEEEEEecc-CCchHHHHHHHHH
Confidence            455788999998   6778999999999999999999877632   22222222   135665543 3345667778888


Q ss_pred             cccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeecc
Q psy12232        159 FKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLV  201 (202)
Q Consensus       159 ~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  201 (202)
                      ++.....+|.|-.+-+.++.+|..|...++.++.|.|..-++|
T Consensus       175 l~~~~~r~iIld~s~~~~~~il~~a~e~gM~~~~y~~ilt~ld  217 (372)
T cd06387         175 MDRRQEKRYLIDCEVERINTILEQVVILGKHSRGYHYMLANLG  217 (372)
T ss_pred             hccccceEEEEECCHHHHHHHHHHHHHcCccccceEEEEecCC
Confidence            8888999999999999999999999999999999999976643

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR3 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).

>cd06390 PBP1_iGluR_AMPA_GluR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA receptor

Probab=95.51  E-value=0.077  Score=48.38  Aligned_cols=111  Identities=10%  Similarity=0.153  Sum_probs=83.3

Q ss_pred             ccccceEeeCCCCCChHHHHHHHHHHhcCCcceeeccccccc---chhhhhhhc-c--CCccccccCCCcchhHHHHHhh
Q psy12232         85 EQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIF---DHKYKSLLQ-N--IPTRHIIAPVEDSRSVKRQLFR  158 (202)
Q Consensus        85 ~~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~---~~ky~~ll~-~--~p~rh~~~~~~~~~~~~~~~~~  158 (202)
                      ...+|.+++.|.   .-.++..++...|-+..+++|++.+..   .+-.+.+-+ +  |.+..+..  .+.+++..+|++
T Consensus        92 ~~~~~~i~~~P~---~~~Ai~diI~~~~W~~v~iIYd~d~g~~~lq~l~~~~~~~~~~I~~~~~~~--~~~~d~~~~L~~  166 (364)
T cd06390          92 TSNQFVLQLRPE---LQDALISVIEHYKWQKFVYIYDADRGLSVLQKVLDTAAEKNWQVTAVNILT--TTEEGYRKLFQD  166 (364)
T ss_pred             CCCceEEEeChh---HHHHHHHHHHHcCCcEEEEEEeCCccHHHHHHHHHhhhccCceeeEEEeec--CChHHHHHHHHh
Confidence            466788898886   667899999999999999999988762   122222222 1  22222222  234689999999


Q ss_pred             cccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeec
Q psy12232        159 FKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL  200 (202)
Q Consensus       159 ~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  200 (202)
                      ++......+++-++.+.+..+|..|.....-++.|.|.+-+.
T Consensus       167 ik~~~~rvIVl~~~~~~~~~~L~~a~~~~~~~~gy~wI~t~l  208 (364)
T cd06390         167 LDKKKERLIVVDCESERLNAILNQIIKLEKNGIGYHYILANL  208 (364)
T ss_pred             ccccCCeEEEEECCHHHHHHHHHHHHHhhccCCceEEEecCC
Confidence            999999999999999999999999977777899999987653

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR1 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).

>PF01094 ANF_receptor: Receptor family ligand binding region The Prosite family is a sub-family of the Pfam family; InterPro: IPR001828 This describes a ligand binding domain and includes extracellular ligand binding domains of a wide range of receptors, as well as the bacterial amino acid binding proteins of known structure []

Probab=95.48  E-value=0.033  Score=47.67  Aligned_cols=114  Identities=10%  Similarity=0.165  Sum_probs=84.0

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccc---cchhhhhhhc--cCCcccc-ccCCC---cchhHHHHH
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFI---FDHKYKSLLQ--NIPTRHI-IAPVE---DSRSVKRQL  156 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~---~~~ky~~ll~--~~p~rh~-~~~~~---~~~~~~~~~  156 (202)
                      .-+|.+++.|+.....+++.+++...+.+..++++++.-.   .-...+.+++  +....+. .....   +.+++.+.|
T Consensus        94 ~~~~~~r~~p~~~~~~~a~~~~l~~~~w~~v~vv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (348)
T PF01094_consen   94 RYPTFFRTVPSDSSQARALVDLLKHFGWTRVSVVYSDDDYGNSLADSFQDLLRERGGICVAFISVVISSDSDAEELLKKL  173 (348)
T ss_dssp             TTTTEEESSB-HHHHHHHHHHHHHHTTSSEEEEEEESSHHHHHHHHHHHHHHHHHTTCEEEEEEEEETTTSHHHHHHHHH
T ss_pred             hccccccccccHHHHHHHHHHhhhcCCCceeeeeccccccccccchhhhhhhcccccceecccccccccccchhhhhhhh
Confidence            5567888888888888899999999999999999998877   1223333333  2333333 22222   356666666


Q ss_pred             hhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeec
Q psy12232        157 FRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL  200 (202)
Q Consensus       157 ~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  200 (202)
                      ++ ......-+++.++...+..+|.+|...++++..|-|.....
T Consensus       174 ~~-~~~~~rvvil~~~~~~~~~~l~~a~~~~~~~~~~~~i~~~~  216 (348)
T PF01094_consen  174 KE-IKSGARVVILCSSPEDARQFLEAAYELGMTSGDYVWILTDL  216 (348)
T ss_dssp             HH-HTTTTSEEEEESBHHHHHHHHHHHHHTTTSSTTSEEEEETT
T ss_pred             hh-ccccceeeeeecccccccccccchhhhhccccceeEEeecc
Confidence            66 55888888999999999999999999999999999997654

; PDB: 3SAJ_D 3Q41_B 3QEM_C 3QEK_A 3QEL_C 3MQ4_A 3QLV_G 3OM1_A 3QLU_A 3OM0_A ....

>cd06392 PBP1_iGluR_delta_1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family

Probab=95.28  E-value=0.055  Score=50.50  Aligned_cols=114  Identities=11%  Similarity=0.190  Sum_probs=84.3

Q ss_pred             ccccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc---hhhhhhhcc---CCcccc-------ccCCCcchh
Q psy12232         85 EQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD---HKYKSLLQN---IPTRHI-------IAPVEDSRS  151 (202)
Q Consensus        85 ~~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~---~ky~~ll~~---~p~rh~-------~~~~~~~~~  151 (202)
                      ...+|.+.+.|+ ...-.++..++...+-....++||+.+...   +-+..+-++   |-++.+       +...- .+.
T Consensus       111 ~~~~~~~~lrp~-~~~~~Ai~dlV~~~~W~~v~~iYD~d~gl~~lq~L~~~~~~~~~~I~~~~v~~~~~~~~~~~l-~~~  188 (400)
T cd06392         111 EGEEYTLAARPP-VRLNDVMLKLVTELRWQKFIVFYDSEYDIRGLQSFLDQASRLGLDVSLQKVDRNISRVFTNLF-TTM  188 (400)
T ss_pred             CcCceeEEecCc-hHHHHHHHHHHHhCCCcEEEEEEECcccHHHHHHHHHHHhhcCceEEEEEcccCcchhhhhHH-HHH
Confidence            466888888886 344557999999999999999999886632   323222221   112221       11111 466


Q ss_pred             HHHHHhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeecc
Q psy12232        152 VKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITLV  201 (202)
Q Consensus       152 ~~~~~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  201 (202)
                      +.++|.++++.+ ..|.|..+.+.+..+|..|...++.++.|.|.+-+.+
T Consensus       189 ~~~~L~~~~~~~-r~iVv~~s~~~~~~il~qA~~lgM~~~~y~wI~t~~~  237 (400)
T cd06392         189 KTEELNRYRDTL-RRAILLLSPRGAQTFINEAVETNLASKDSHWVFVNEE  237 (400)
T ss_pred             HHhhhhhccccc-eEEEEEcCcHHHHHHHHHHHHhCcccCCeEEEEecCC
Confidence            788999999999 9999999999999999999999999999999986653

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta1 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 may be closer related to non-NMDA receptors. In contrast to GluRdelta2, GluRdel

>KOG4721|consensus

Probab=95.11  E-value=0.014  Score=57.92  Aligned_cols=27  Identities=33%  Similarity=0.720  Sum_probs=24.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSKLD   29 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~Le   29 (202)
                      +--||++||+.+|.+||+|.+|+.+|+
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            345899999999999999999999997

>cd06389 PBP1_iGluR_AMPA_GluR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA receptor

Probab=94.29  E-value=0.25  Score=44.80  Aligned_cols=109  Identities=9%  Similarity=0.169  Sum_probs=80.0

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhcc-------CCccccccCCC---cchhHHHH
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQN-------IPTRHIIAPVE---DSRSVKRQ  155 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~-------~p~rh~~~~~~---~~~~~~~~  155 (202)
                      ...|.+++.|+   .-.++..++...+-...+++|++.|... -.+.+++.       |.... ...+.   ...+...+
T Consensus        94 ~~~f~~~~~p~---~~~ai~d~i~~~~wk~vailYdsd~gl~-~lq~l~~~~~~~g~~V~~~~-~~~i~~~~~~~d~~~~  168 (370)
T cd06389          94 THPFVIQMRPD---LKGALLSLIEYYQWDKFAYLYDSDRGLS-TLQAVLDSAAEKKWQVTAIN-VGNINNDRKDEAYRSL  168 (370)
T ss_pred             CCceEEEecch---hhhHHHHHHHhcCCcEEEEEecCchHHH-HHHHHHHhhccCCceEEEEE-eecCCCccchHHHHHH
Confidence            45677788877   4566777889999999999999776521 11122221       11111 11111   24589999


Q ss_pred             HhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        156 LFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       156 ~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      |+++|....-.+++-++.+.+..+|..|...++.++.|.|+.-+
T Consensus       169 L~~ik~~~~~~Iil~~~~~~~~~il~qa~~~gm~~~~y~~il~~  212 (370)
T cd06389         169 FQDLENKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIAN  212 (370)
T ss_pred             HHHhccccceEEEEECCHHHHHHHHHHHHHhCccccceEEEEcc
Confidence            99999999999999999999999999999999999999997643

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR2 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).

>cd06379 PBP1_iGluR_NMDA_NR1 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor

Probab=94.18  E-value=0.18  Score=45.16  Aligned_cols=112  Identities=14%  Similarity=0.204  Sum_probs=77.6

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccc-cccc--hhhhhhhc--cC----CccccccCCCcchhHHHHHh
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDS-FIFD--HKYKSLLQ--NI----PTRHIIAPVEDSRSVKRQLF  157 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~-f~~~--~ky~~ll~--~~----p~rh~~~~~~~~~~~~~~~~  157 (202)
                      -+|.+...|+....-.++..++...+.+..+++++++ |.-.  -..+..++  ++    .......--.+..++..+|+
T Consensus       128 ~~~~~R~~psd~~~~~a~~~~l~~~~w~~vaii~~~~~~g~~~~~~~~~~~~~~g~~~~~~v~~~~~~~~~~~d~~~~l~  207 (377)
T cd06379         128 HLSFLRTVPPYSHQADVWLEMLRSFKWNKVILLVSDDHEGRAAQKRFETLLEEREIEFKIKVEKVVEFEPGEKNVTSLLQ  207 (377)
T ss_pred             cccEEEecCCHHHHHHHHHHHHHHcCCeEEEEEEEcCcchhHHHHHHHHHHHhcCCccceeeeEEEecCCchhhHHHHHH
Confidence            3566666666554455666778888999999998765 3311  12223333  12    11211111113468899999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      +++..+.--+++.|.......++..|...++.|..|.|..-
T Consensus       208 ~ik~~~~~vIvl~~~~~~~~~l~~qa~~~g~~~~~~~wi~t  248 (377)
T cd06379         208 EAKELTSRVILLSASEDDAAVIYRNAGMLNMTGEGYVWIVS  248 (377)
T ss_pred             HHhhcCCeEEEEEcCHHHHHHHHHHHHHcCCCCCCEEEEEe
Confidence            99998888889999999999999999999999999999853

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR1, an essential channel-forming subunit of the NMDA receptor. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer ccomposed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. When co-expressed with NR1, the NR3 subunits form receptors that are activated by glycine alone and therefore

>cd06380 PBP1_iGluR_AMPA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA receptor

Probab=94.08  E-value=0.3  Score=43.61  Aligned_cols=110  Identities=12%  Similarity=0.100  Sum_probs=76.6

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-----c--CCcccc-ccCCCcchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-----N--IPTRHI-IAPVEDSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-----~--~p~rh~-~~~~~~~~~~~~~~~  157 (202)
                      ..+|.+.+.|+ .  -.++..++...+....+++|+++..... .+.+++     +  +..... .....+.+++..||+
T Consensus       102 ~~~~~fr~~p~-~--~~a~~~~~~~~~wk~vaii~~~~~~~~~-~~~~~~~~~~~g~~i~v~~~~~~~~~~~~d~~~~L~  177 (382)
T cd06380         102 GNQFVLQMRPS-L--IQALVDLIEHYGWRKVVYLYDSDRGLLR-LQQLLDYLREKDNKWQVTARRVDNVTDEEEFLRLLE  177 (382)
T ss_pred             CCcEEEEeccc-h--hHHHHHHHHhcCCeEEEEEECCCcchHH-HHHHHHHHhccCCceEEEEEEecCCCcHHHHHHHHH
Confidence            45677776664 2  2356677788899999999987764221 122222     2  111110 111112468999999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ++|..+...+++.+..+....++..|....+.++.|.|+.-+
T Consensus       178 ~ik~~~~~~iil~~~~~~~~~i~~qa~~~gm~~~~y~~i~~~  219 (382)
T cd06380         178 DLDRRKEKRIVLDCESERLNKILEQIVDVGKNRKGYHYILAN  219 (382)
T ss_pred             HhhcccceEEEEECCHHHHHHHHHHHHHhhhcccceEEEEcc
Confidence            999998888888999999999999999999999999997643

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, a member of the glutamate-receptor ion channels (iGluRs). AMPA receptors are the major mediators of excitatory synaptic transmission in the central nervous system. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. AMPA receptors consist of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important roles in mediating the rapid excita

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=94.07  E-value=0.034  Score=48.85  Aligned_cols=25  Identities=20%  Similarity=0.367  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+++.+||+.+|.+|||+.+|+.
T Consensus       274 ~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         274 EFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             HHHHHHHHhccCCcccCcCHHHHhh
Confidence            3578999999999999999998874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06381 PBP1_iGluR_delta_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2

Probab=93.84  E-value=0.2  Score=45.61  Aligned_cols=109  Identities=15%  Similarity=0.290  Sum_probs=70.7

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-----cCCccccccCCC-cchhHH------
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-----NIPTRHIIAPVE-DSRSVK------  153 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-----~~p~rh~~~~~~-~~~~~~------  153 (202)
                      ..+|.+.+.|. +....++..++...+-...+++|+++.... -.+.+++     +++..  ..... +...+-      
T Consensus       112 ~~~~~f~~rp~-~~~~~ai~~lv~~~~wkkvavly~~d~g~~-~l~~~~~~~~~~g~~v~--~~~~~~~~~~~~~~l~~~  187 (363)
T cd06381         112 GQQYTLALRPP-VRLNDVMLRLVTEWRWQKFVYFYDNDYDIR-GLQEFLDQLSRQGIDVL--LQKVDLNISKMATALFTT  187 (363)
T ss_pred             cceeEEEEecc-HHHHHHHHHHHHhCCCeEEEEEEECCchHH-HHHHHHHHHHhcCceEE--EEecccccchhhhhhhhH
Confidence            45688877765 456677888888889888899999886421 1122222     11111  11111 111111      


Q ss_pred             ---HHHhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        154 ---RQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       154 ---~~~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                         ++|.|++. +...+++.++.+.+..+|..|...++.++.|.|+.++
T Consensus       188 ~~~~~l~~~~~-~~~~vIl~~~~~~~~~~l~~a~~~gm~~~~~~wi~~~  235 (363)
T cd06381         188 MRCEELNRYRD-TLRRALLLLSPNGAYTFIDASVETNLAIKDSHWFLIN  235 (363)
T ss_pred             HHHHHHHhhcc-cceEEEEEcCcHHHHHHHHHHHHcCCCcCceEEEEec
Confidence               22333333 5567788899999999999999999999999999865

This CD represents the N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of an orphan family of delta receptors, GluRdelta1 and GluRdelta2. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are more homologous to non-NMDA receptors. G

>KOG0194|consensus

Probab=93.70  E-value=0.061  Score=51.72  Aligned_cols=35  Identities=20%  Similarity=0.494  Sum_probs=31.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+..+|.+||..+|.+||+|.++.+.++.+.....
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            46789999999999999999999999998887654

>cd06388 PBP1_iGluR_AMPA_GluR4 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA receptor

Probab=93.46  E-value=0.39  Score=43.80  Aligned_cols=108  Identities=11%  Similarity=0.205  Sum_probs=79.3

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc----c---CCccccccCCCcchhHHHHHhh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ----N---IPTRHIIAPVEDSRSVKRQLFR  158 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~----~---~p~rh~~~~~~~~~~~~~~~~~  158 (202)
                      ...|++++.|+   .-.++..++...+-...+|+||...... ..+.+++    +   +..+.+.. . +..+...+|++
T Consensus       100 ~~~f~i~~~p~---~~~a~~~~i~~~~wk~vaiiYd~~~~~~-~lq~l~~~~~~~g~~v~~~~~~~-~-~~~d~~~~L~~  173 (371)
T cd06388         100 ESQFVLQLRPS---LRGALLSLLDHYEWNRFVFLYDTDRGYS-ILQAIMEKAGQNGWQVSAICVEN-F-NDASYRRLLED  173 (371)
T ss_pred             CCceEEEeChh---hhhHHHHHHHhcCceEEEEEecCCccHH-HHHHHHHhhHhcCCeeeeEEecc-C-CcHHHHHHHHH
Confidence            44566777777   3455666788889999999998666431 1333333    1   12222211 1 24699999999


Q ss_pred             cccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        159 FKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       159 ~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ++......+++-++-+.+..+|..|...++-++.|.|+.-+
T Consensus       174 ik~~~~~~iil~~~~~~~~~il~qa~~~gm~~~~y~~il~~  214 (371)
T cd06388         174 LDRRQEKKFVIDCEIERLQNILEQIVSVGKHVKGYHYIIAN  214 (371)
T ss_pred             hcccccEEEEEECCHHHHHHHHHHHHhcCccccceEEEEcc
Confidence            99999999999999999999999999999999999998744

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the GluR4 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor. The AMPA receptor is a member of the glutamate-receptor ion channels (iGluRs) which are the major mediators of excitatory synaptic transmission in the central nervous system. AMPA receptors are composed of four types of subunits (GluR1, GluR2, GluR3, and GluR4) which combine to form a tetramer and play an important role in mediating the rapid excitatory synaptic current. Furthermore, this N-terminal domain of the iGluRs has homology with LIVBP, a bacterial periplasmic binding protein, as well as with the structurally related glutamate-binding domain of the G-protein-coupled metabotropic receptors (mGluRs).

>cd06269 PBP1_glutamate_receptors_like Family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors

Probab=93.39  E-value=0.28  Score=40.37  Aligned_cols=113  Identities=14%  Similarity=0.191  Sum_probs=77.0

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccc---cchhhhhhhcc--CCccccccCCCcchhHHHHHhhcc
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFI---FDHKYKSLLQN--IPTRHIIAPVEDSRSVKRQLFRFK  160 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~---~~~ky~~ll~~--~p~rh~~~~~~~~~~~~~~~~~~~  160 (202)
                      +.+|.+++.|+.....+++..++...+-+..++++++.-.   +-..++..+++  +-.+-.........++..++++++
T Consensus       113 ~~~~~~~~~p~~~~~~~a~~~~l~~~~w~~v~~v~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~l~~l~  192 (298)
T cd06269         113 QFPSFLRTVPSDSSQAQAIVDLLKHFGWTWVGLVYSDDDYGRRLLELLEEELEKNGICVAFVESIPDGSEDIRRLLKELK  192 (298)
T ss_pred             hCCCeEecCCCcHHHHHHHHHHHHHCCCeEEEEEEecchhhHHHHHHHHHHHHHCCeeEEEEEEcCCCHHHHHHHHHHHH
Confidence            5678888888877788888889999999888999887631   11222333332  111111111111257888999999


Q ss_pred             cCceeeeeeecch-hhHHHHHhhhhhhhcccccceeEEeec
Q psy12232        161 DLDIVNYFILGRL-QTIKMILDSANVNKFFGRKFAWHAITL  200 (202)
Q Consensus       161 ~~d~~n~f~~g~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~  200 (202)
                      +.+. +.+|+... +.+..+|+.|...++. .+|-|...+.
T Consensus       193 ~~~~-~viv~~~~~~~~~~~l~~a~~~g~~-~~~~~i~~~~  231 (298)
T cd06269         193 SSTA-RVIVVFSSEEDALRLLEEAVELGMM-TGYHWIITDL  231 (298)
T ss_pred             hcCC-cEEEEEechHHHHHHHHHHHHcCCC-CCeEEEEECh
Confidence            8887 66666554 8999999999999998 7888877654

This CD represents the ligand-binding domain of the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine/isoleucine/valine- binding protein (LIVBP)-like domain of the ionotropic glutamate receptors, all of which are structurally similar and related to the periplasmic-binding fold type I family. The family C GPCRs consist of metabotropic glutamate receptor (mGluR) receptors, a calcium-sensing receptor (CaSR), gamma-aminobutyric receptors (GABAb), the promiscuous L-alpha-amino acid receptor GPR6A, families of taste and pheromone receptors, and orphan receptors. Truncated splicing va

>cd06394 PBP1_iGluR_Kainate_KA1_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor

Probab=93.32  E-value=0.26  Score=44.74  Aligned_cols=107  Identities=14%  Similarity=0.146  Sum_probs=80.4

Q ss_pred             eEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-cCCccccccCCC--cchhHHHHHhhcccCceee
Q psy12232         90 LIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-NIPTRHIIAPVE--DSRSVKRQLFRFKDLDIVN  166 (202)
Q Consensus        90 Llqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-~~p~rh~~~~~~--~~~~~~~~~~~~~~~d~~n  166 (202)
                      .+++.|.......++..++...|-....++|++.-.+-. -..+|+ ..+++-.+....  +..++..||+++++...-.
T Consensus       111 ~i~l~P~~~~~~~Ai~dli~~~~W~~v~~iYe~d~~l~~-L~~~l~~~~~~~~~i~~~~~~~~~d~~~~L~~ik~~~~~~  189 (333)
T cd06394         111 SVNLHPSNEDISVAVAGILNSFNYPTASLICAKAECLLR-LEELLRQFLISKETLSVRMLDDSRDPTPLLKEIRDDKTAT  189 (333)
T ss_pred             EEEecCCHHHHHHHHHHHHHhcCCCEEEEEEeCcHHHHH-HHHHHHhhcccCCceeeEEccCcccHHHHHHHHHhcCCCE
Confidence            367777666677889999999999999999987642110 011122 122222222222  4568999999999999999


Q ss_pred             eeeecchhhHHHHHhhhhhhhcccccceeEE
Q psy12232        167 YFILGRLQTIKMILDSANVNKFFGRKFAWHA  197 (202)
Q Consensus       167 ~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~  197 (202)
                      |++-++.+....+|..|+...+-++.|+|.+
T Consensus       190 iVv~~~~~~a~~il~qa~~lGm~~~~y~~i~  220 (333)
T cd06394         190 IIIDANASMSHTILLKASELGMTSAFYKYIL  220 (333)
T ss_pred             EEEECChHHHHHHHHHHHHcCCCCCceEEEE
Confidence            9999999999999999999999999999984

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the KA1 and KA2 subunits of Kainate receptor. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. There are five types of kainate receptors, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeric receptor channels act

>cd06386 PBP1_NPR_C_like Ligand-binding domain of type C natriuretic peptide receptor

Probab=93.19  E-value=0.35  Score=43.80  Aligned_cols=108  Identities=12%  Similarity=0.116  Sum_probs=77.5

Q ss_pred             eEeeCCCCCChHHHHHHHHHHhcCCcceeecccc-cc------cchhhhhhhc--cCCccccccCCCcchhHHHHHhhcc
Q psy12232         90 LIQVNPPGDILPEVIRAIILMQNITDAGILFDDS-FI------FDHKYKSLLQ--NIPTRHIIAPVEDSRSVKRQLFRFK  160 (202)
Q Consensus        90 Llqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~-f~------~~~ky~~ll~--~~p~rh~~~~~~~~~~~~~~~~~~~  160 (202)
                      ++.+.|+....-.++..++...|-+..+++++++ |.      ++.-.+ .++  ++-......--.+..+...+|++++
T Consensus       114 ~~R~~p~~~~~~~a~~~ll~~~~W~~vaiiy~~~~~~~~~~~~~~~l~~-~~~~~gi~v~~~~~~~~~~~d~~~~l~~ik  192 (387)
T cd06386         114 LTRVAPSYVKMGETFSALFERFHWRSALLVYEDDKQERNCYFTLEGVHH-VFQEEGYHMSIYPFDETKDLDLDEIIRAIQ  192 (387)
T ss_pred             eEEecCchHHHHHHHHHHHHhCCCeEEEEEEEcCCCCccceehHHHHHH-HHHhcCceEEEEecCCCCcccHHHHHHHHH
Confidence            7888887776777778888888999999998644 32      222222 222  3222221111112458899999999


Q ss_pred             cCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        161 DLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       161 ~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +.. --+++.++.+.+..++.+|...++.+..|.|..+.
T Consensus       193 ~~~-rvii~~~~~~~~~~ll~~A~~~gm~~~~yv~i~~d  230 (387)
T cd06386         193 ASE-RVVIMCAGADTIRSIMLAAHRRGLTSGDYIFFNIE  230 (387)
T ss_pred             hcC-cEEEEecCHHHHHHHHHHHHHcCCCCCCEEEEEEe
Confidence            988 77778889999999999999999999999998873

Ligand-binding domain of type C natriuretic peptide receptor (NPR-C). NPR-C is found in atrial, mesentery, placenta, lung, kidney, venous tissue, aortic smooth muscle, and aortic endothelial cells. The affinity of NPR-C for natriuretic peptides is ANPCNPBNP. The extracellular domain of NPR-C is about 30% identical to NPR-A and NPR-B. However, unlike the cyclase-linked receptors, it contains only 37 intracellular amino acids and no guanylyl cyclase activity. Major function of NPR-C is to clear natriuretic peptides from the circulation or extracellular surroundings through constitutive receptor-mediated internalization and degradation.

>cd06391 PBP1_iGluR_delta_2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family

Probab=93.18  E-value=0.41  Score=44.31  Aligned_cols=113  Identities=12%  Similarity=0.196  Sum_probs=74.9

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-----cCCcc--ccccCCCc-c-hhH-HHH
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-----NIPTR--HIIAPVED-S-RSV-KRQ  155 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-----~~p~r--h~~~~~~~-~-~~~-~~~  155 (202)
                      ..+|-+.+.|+ .....++.+++...|-+..++++|+.+.. .--..|++     ++...  .+...+.+ . ... ..+
T Consensus       112 ~~~y~~~~rp~-~~~~~ai~~li~~f~W~~v~i~~d~~~~~-~~l~~l~~~~~~~~i~I~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd06391         112 NDDYTLSVRPP-VYLNDVILRVVTEYAWQKFIIFYDTDYDI-RGIQEFLDKVSQQGMDVALQKVENNINKMITGLFRTMR  189 (400)
T ss_pred             cccceEEecCh-HHHHHHHHHHHHHcCCcEEEEEEeCCccH-HHHHHHHHHHHHcCCeEEEEecCcchhhhhHHHHHHHH
Confidence            45677777765 44557789999999999999999988774 22223331     33221  11111000 0 011 225


Q ss_pred             Hhhccc--CceeeeeeecchhhHHHHHhhhhhhhcccccceeEEeec
Q psy12232        156 LFRFKD--LDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAITL  200 (202)
Q Consensus       156 ~~~~~~--~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  200 (202)
                      ++.|+.  -+...+.+-++.+.+..+|..|...++.|++|.|..-+.
T Consensus       190 ~~~l~~~~~~~rviVl~~~~~~~~~ll~~a~~~gm~~~~y~wi~t~~  236 (400)
T cd06391         190 IEELNRYRDTLRRAILVMNPATAKSFITEVVETNLVAFDCHWIIINE  236 (400)
T ss_pred             HHHHHhhcccccEEEEECCcHHHHHHHHHHHHcCCCCCCeEEEEeCc
Confidence            555554  234778888999999999999999999999999998665

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the delta2 receptor of an orphan glutamate receptor family. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Although the delta receptors are a member of the ionotropic glutamate receptor family, they cannot be activated by AMPA, kainate, NMDA, glutamate, or any other ligands. Phylogenetic analysis shows that both GluRdelta1 and GluRalpha2 are closer related to non-NMDA receptors. GluRdelta2 was shown to function as a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=93.16  E-value=0.058  Score=46.21  Aligned_cols=26  Identities=15%  Similarity=0.368  Sum_probs=22.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+||++.+|+..
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            36789999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06378 PBP1_iGluR_NMDA_NR2 N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family

Probab=92.40  E-value=0.42  Score=43.61  Aligned_cols=115  Identities=12%  Similarity=0.183  Sum_probs=81.8

Q ss_pred             ccccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc---hhhhhhhccC----CccccccC-CCcchhHHHHH
Q psy12232         85 EQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD---HKYKSLLQNI----PTRHIIAP-VEDSRSVKRQL  156 (202)
Q Consensus        85 ~~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~---~ky~~ll~~~----p~rh~~~~-~~~~~~~~~~~  156 (202)
                      .+.+|.++..|+-..-..++.+++..-|=+-.+++++..=..+   ..-+.++++.    -.+.++.. ..+..++...+
T Consensus       107 ~~~p~flr~~Psd~~q~~Ai~~Ii~~f~W~~v~iV~~~~~g~~~~~~~l~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  186 (362)
T cd06378         107 DSGSTFLQFGPSIEQQAAVMLKIMEEYDWHAFSVVTSRFPGYDDFVSAVRTTVDNSFVGWELQSVLTLDMSDDDGDARTQ  186 (362)
T ss_pred             CCCceEEEeCCCHHHHHHHHHHHHHHCCCeEEEEEEEcCCCHHHHHHHHHHHHhhcccceeEEEEEeeccCCCcchHHHH
Confidence            4567889999887778888999999999999888775531100   1112222211    01111111 11233477888


Q ss_pred             hhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        157 FRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       157 ~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +++++.+.--|.+-++.+.+..+++.|...++.|+.|.|.+=+
T Consensus       187 ~~lk~~~arViVl~~s~~~a~~if~~A~~~gm~g~~yvWI~t~  229 (362)
T cd06378         187 RQLKKLESQVILLYCSKEEAEYIFRAARSAGLTGPGYVWIVPS  229 (362)
T ss_pred             HHHHhcCCCEEEEECCHHHHHHHHHHHHHcCCcCCCeEEEecc
Confidence            9999999999999999999999999999999999999998744

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family. The ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer composed of two NR1 and two NR2 (A, B, C, and D) or of NR3 (A and B) subunits. The receptor controls a cation channel that is highly permeable to monovalent ions and calcium and exhibits voltage-dependent inhibition by magnesium. Dual agonists, glutamate and glycine, are required for efficient activation of the NMDA receptor. Among NMDA receptor subtypes, the NR2B subunit containing receptors appear particularly important for pain perception; thus NR2B-selective antagonists may be useful in

>KOG1023|consensus

Probab=92.39  E-value=0.093  Score=50.61  Aligned_cols=34  Identities=29%  Similarity=0.434  Sum_probs=30.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVT   35 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~   35 (202)
                      .+..+|.+||..+|..||+|.++...+..+....
T Consensus       195 ~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  195 ELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             HHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            3678999999999999999999999998887754

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=92.19  E-value=0.09  Score=45.27  Aligned_cols=26  Identities=8%  Similarity=0.157  Sum_probs=23.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+++++.+||..+|.+||++.+++.+
T Consensus       264 ~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         264 EAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhC
Confidence            36789999999999999999998854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=91.82  E-value=0.14  Score=44.12  Aligned_cols=26  Identities=15%  Similarity=0.323  Sum_probs=22.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+||++.+++..
T Consensus       242 ~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         242 YFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            36789999999999999999988754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06385 PBP1_NPR_A Ligand-binding domain of type A natriuretic peptide receptor

Probab=91.18  E-value=0.89  Score=41.05  Aligned_cols=110  Identities=12%  Similarity=0.155  Sum_probs=76.2

Q ss_pred             cceEeeCCCCCChHHHHHHHHHHhcCCcce-eecccc-c-------ccchhhhhhhc-cCCccccccCCCcchhHHHHHh
Q psy12232         88 KYLIQVNPPGDILPEVIRAIILMQNITDAG-ILFDDS-F-------IFDHKYKSLLQ-NIPTRHIIAPVEDSRSVKRQLF  157 (202)
Q Consensus        88 ~YLlqv~pp~~~~pe~vr~~~~~~nit~Ag-i~~d~~-f-------~~~~ky~~ll~-~~p~rh~~~~~~~~~~~~~~~~  157 (202)
                      +|++.+.|+......++..++...|-+.-+ |++++. +       .+++-.+.+-+ ++......-.-.+..++..+|+
T Consensus       118 ~~~~R~~p~~~~~~~a~~~~~~~~~w~~va~ii~~~~~~~~~~~~~~~~~l~~~~~~~gi~v~~~~~~~~~~~d~~~~l~  197 (405)
T cd06385         118 ATITRTGPTHKKLGEFVLHIHQHFGWRSHAMLIYSDNKVDDRPCYFAMEGLYMELKKNNITVVDLVFEEDDLINYTTLLQ  197 (405)
T ss_pred             cceEEecCchHHHHHHHHHHHHhCCCeEEEEEEEecCcccccchHHHHHHHHHHHHhCCeEEEEeeccCCchhhHHHHHH
Confidence            466788887777777777788888888755 555432 2       35565555533 3433332111013568889999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ++++.. -=+++.|.......++..|...++.+..|.|...
T Consensus       198 ~ik~~~-~iii~~~~~~~~~~i~~~a~~~g~~~~~y~~i~~  237 (405)
T cd06385         198 DIKQKG-RVIYVCCSPDIFRRLMLQFWREGLPSEDYVFFYI  237 (405)
T ss_pred             HHhhcc-eEEEEeCCHHHHHHHHHHHHHcCCCCCcEEEEEe
Confidence            998865 4556669999999999999999999999999865

Ligand-binding domain of type A natriuretic peptide receptor (NPR-A). NPR-A is one of three known single membrane-spanning natriuretic peptide receptors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. NPR-A is highly expressed in kidney, adrenal, terminal ileum, adipose, aortic, and lung tissues. The rank order of NPR-A activation by natriuretic peptides is ANPBNPCNP. Single allele-inactivating mutations in the promoter of human NPR-A are associated with hypertension and heart failure.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=91.16  E-value=0.11  Score=45.23  Aligned_cols=26  Identities=8%  Similarity=0.238  Sum_probs=22.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.++|.+||+.+|.+|||+.+++..
T Consensus       267 ~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         267 KALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            36789999999999999999988755

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=90.40  E-value=0.17  Score=43.56  Aligned_cols=24  Identities=13%  Similarity=0.324  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       266 ~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         266 ALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHHHcCcCcccCCCHHHHhc
Confidence            578999999999999999998874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06368 PBP1_iGluR_non_NMDA_like N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors

Probab=90.12  E-value=1.1  Score=38.58  Aligned_cols=110  Identities=12%  Similarity=0.123  Sum_probs=71.1

Q ss_pred             ceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhccCCc--cccccCC--CcchhHHHHHhhcccCce
Q psy12232         89 YLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPT--RHIIAPV--EDSRSVKRQLFRFKDLDI  164 (202)
Q Consensus        89 YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~~p~--rh~~~~~--~~~~~~~~~~~~~~~~d~  164 (202)
                      |...+.|+....-.++..++...+-...++++++... ....+.+++..--  ..+-...  ...+++..+|.+++....
T Consensus       103 ~~~~~~~~~~~~~~a~~~~~~~~~w~~vaii~~~~~~-~~~l~~~~~~~~~~g~~v~~~~~~~~~~d~~~~l~~i~~~~~  181 (324)
T cd06368         103 FTINLYPSMRDLSDALLDLIKYFGWRKFVYIYDSDEG-LLRLQELLDALSPKGIQVTVRRLDDDTDMYRPLLKEIKREKE  181 (324)
T ss_pred             ceEEecCCHHHHHHHHHHHHHhcCCCEEEEEECCcHh-HHHHHHHHHhhccCCceEEEEEecCCchHHHHHHHHHhhccC
Confidence            4444444432333445556777777888999987642 1222333332110  0111111  123479999999999887


Q ss_pred             eeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        165 VNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       165 ~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      .-.++.+..+....++..|....+.+..|.|...+
T Consensus       182 d~Vi~~~~~~~~~~i~~qa~~~g~~~~~~~~i~~~  216 (324)
T cd06368         182 RRIILDCSPERLKEFLEQAVEVGMMSEYYHYILTN  216 (324)
T ss_pred             ceEEEECCHHHHHHHHHHHHHhccccCCcEEEEcc
Confidence            77788999999999999999999999999998754

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the non-NMDA (N-methyl-d-asparate) subtypes of ionotropic glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Glutamate mediates the majority of excitatory synaptic transmission in the central nervous system via two broad classes of ionotropic receptors, characterized by their response to glutamate agonists: N-methyl-d -aspartate (NMDA) and non-NMDA receptors. NMDA receptors

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=90.07  E-value=0.21  Score=43.18  Aligned_cols=27  Identities=15%  Similarity=0.353  Sum_probs=24.0

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSKLD   29 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~Le   29 (202)
                      +.+++.+||+.+|.+||++.+++...-
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChh
Confidence            678999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=89.69  E-value=0.16  Score=43.46  Aligned_cols=28  Identities=11%  Similarity=-0.066  Sum_probs=23.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLD   29 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le   29 (202)
                      .+.+++.+||+.+|.+||++.++.+.|+
T Consensus       245 ~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         245 DAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHHHhccChhhccCccCHHHHHh
Confidence            3789999999999999999976666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=89.57  E-value=0.26  Score=42.89  Aligned_cols=26  Identities=8%  Similarity=0.217  Sum_probs=23.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||+.+|.+|||+.+++..
T Consensus       270 ~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         270 DALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhccCCcccccCHHHHhhC
Confidence            36789999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=89.50  E-value=0.19  Score=43.83  Aligned_cols=25  Identities=12%  Similarity=0.235  Sum_probs=22.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      +.+++++||+.+|.+|||+.+++.+
T Consensus       267 ~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         267 AIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHHHHHHHhcCChhhccCHHHHHcC
Confidence            5689999999999999999998866

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06367 PBP1_iGluR_NMDA N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors

Probab=88.82  E-value=1.5  Score=38.87  Aligned_cols=114  Identities=12%  Similarity=0.189  Sum_probs=74.4

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccch---hhhhhhc--cCC--cccccc-CCCcchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDH---KYKSLLQ--NIP--TRHIIA-PVEDSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~---ky~~ll~--~~p--~rh~~~-~~~~~~~~~~~~~  157 (202)
                      ...|.+...|+....-.++..++...|-+..+++++++=.-..   ..+.+++  ++.  ...... ......+....+.
T Consensus       109 ~~~~~~R~~p~~~~~~~ai~~ll~~~~w~~vaii~~~~~~g~~~~~~l~~~l~~~g~~~~i~~~~~~~~~~~~~~~~~l~  188 (362)
T cd06367         109 IHSLFLQTGPSLEQQADVMLEILEEYDWHQFSVVTSRDPGYRDFLDRVETTLEESFVGWEFQLVLTLDLSDDDGDARLLR  188 (362)
T ss_pred             cccceEeecCcHHHHHHHHHHHHHHcCCeEEEEEEEcCcccHHHHHHHHHHHHhcccceeeeeeEEeccCCCcchHHHHH
Confidence            4457778888777777778889999999988999975422011   1122233  111  111110 1111224556666


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ++++...--+++.|+......++..|...++.++.|.|..-.
T Consensus       189 ~l~~~~~~vivl~~~~~~~~~il~~a~~~g~~~~~~~wI~~~  230 (362)
T cd06367         189 QLKKLESRVILLYCSKEEAERIFEAAASLGLTGPGYVWIVGE  230 (362)
T ss_pred             HHHhcCCcEEEEeCCHHHHHHHHHHHHHcCCCCCCcEEEECc
Confidence            666665556688899999999999999999999999998754

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the ionotropic N-methyl-d-asparate (NMDA) subtype of glutamate receptors. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. The function of the NMDA subtype receptor serves critical functions in neuronal development, functioning, and degeneration in the mammalian central nervous system. The functional NMDA receptor is a heterotetramer comprising two NR1 and two NR2 (A, B, C, and D) or NR3 (A and B) subunits

>cd06382 PBP1_iGluR_Kainate N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors

Probab=88.82  E-value=1.7  Score=37.79  Aligned_cols=111  Identities=14%  Similarity=0.147  Sum_probs=73.0

Q ss_pred             cceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhccCCc---cccccCCCcchhHHHHHhhcccCce
Q psy12232         88 KYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPT---RHIIAPVEDSRSVKRQLFRFKDLDI  164 (202)
Q Consensus        88 ~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~~p~---rh~~~~~~~~~~~~~~~~~~~~~d~  164 (202)
                      +|.+...|+....-..+..++...+....++++++.= ..-..+.+++..-.   ...........++..+|.+++..+.
T Consensus       104 ~~~fr~~p~~~~~~~a~~~~~~~~~w~~vavl~~~~~-~~~~l~~~~~~~~~~g~~v~~~~~~~~~d~~~~l~~i~~~~~  182 (327)
T cd06382         104 QFTINLYPSNADLSRAYADIVKSFNWKSFTIIYESAE-GLLRLQELLQAFGISGITITVRQLDDDLDYRPLLKEIKNSGD  182 (327)
T ss_pred             cceEEeCCCHHHHHHHHHHHHHhcCCcEEEEEecChH-HHHHHHHHHHhhccCCCeEEEEEccCCccHHHHHHHHHhcCc
Confidence            4666665554444444555666677777788888652 11222233331100   0011111112289999999999998


Q ss_pred             eeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        165 VNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       165 ~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ..+++.|.......++..|....+.+..|.|....
T Consensus       183 d~vv~~~~~~~~~~~~~qa~~~g~~~~~~~~i~~~  217 (327)
T cd06382         183 NRIIIDCSADILIELLKQAQQVGMMSEYYHYIITN  217 (327)
T ss_pred             eEEEEECCHHHHHHHHHHHHHhCccccceEEEEec
Confidence            88899999999999999999999999999997643

N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the kainate receptors, non-NMDA ionotropic receptors which respond to the neurotransmitter glutamate. While this N-terminal domain belongs to the periplasmic-binding fold type I superfamily, the glutamate-binding domain of the iGluR is structurally homologous to the periplasmic-binding fold type II. The LIVBP-like domain of iGluRs is thought to play a role in the initial assembly of iGluR subunits, but it is not well understood how this domain is arranged and functions in intact iGluR. Kainate receptors have five subunits, GluR5, GluR6, GluR7, KA1, and KA2, which are structurally similar to AMPA and NMDA subunits of ionotropic glutamate receptors. KA1 and KA2 subunits can only form functional receptors with one of the GluR5-7 subunits. Moreover, GluR5-7 can also form functional homomeri

>cd06373 PBP1_NPR_like Ligand binding domain of natriuretic peptide receptor (NPR) family

Probab=87.96  E-value=1.9  Score=38.71  Aligned_cols=109  Identities=18%  Similarity=0.146  Sum_probs=70.9

Q ss_pred             cceEeeCCCCCChHHHHHHHHHHhcCCcceeeccc-ccc------cchhhhhhhc--cCCccccccCCCc--chhHHHHH
Q psy12232         88 KYLIQVNPPGDILPEVIRAIILMQNITDAGILFDD-SFI------FDHKYKSLLQ--NIPTRHIIAPVED--SRSVKRQL  156 (202)
Q Consensus        88 ~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~-~f~------~~~ky~~ll~--~~p~rh~~~~~~~--~~~~~~~~  156 (202)
                      +|++...|+....-..+..++...+....++++++ .+.      .-...+..++  ++...... -...  ..+...+|
T Consensus       117 ~~~fr~~p~~~~~~~a~~~~~~~~~w~~vaii~~~~~~~~~~~~~~~~~~~~~~~~~g~~v~~~~-~~~~~~~~d~~~~l  195 (396)
T cd06373         117 STLTRTGPSYTKLGEFVLALHEHFNWSRAALLYHDDKNDDRPCYFTLEGVYTVLKEENITVSDFP-FDEDKELDDYKELL  195 (396)
T ss_pred             CceeeccccHHHHHHHHHHHHHHcCCeEEEEEEECCCCCcchHHHHHHHHHHHHhhcCceeeEEe-ecCCccccCHHHHH
Confidence            45777777665555566667777888888999764 331      1122333333  22221111 1111  26788888


Q ss_pred             hhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        157 FRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       157 ~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ++++.-. --+++.|.......++..|...++.+..|-|..+
T Consensus       196 ~~ik~~~-~vii~~~~~~~~~~~~~qa~~~g~~~~~yv~i~~  236 (396)
T cd06373         196 RDISKKG-RVVIMCASPDTVREIMLAAHRLGLTSGEYVFFNI  236 (396)
T ss_pred             HHHHhcC-cEEEEecCHHHHHHHHHHHHHcCCCCCcEEEEEE
Confidence            8887755 5556778888999999999999999999988764

Ligand binding domain of natriuretic peptide receptor (NPR) family which consists of three different subtypes: type A natriuretic peptide receptor (NPR-A, or GC-A), type B natriuretic peptide receptors (NPR-B, or GC-B), and type C natriuretic peptide receptor (NPR-C). There are three types of natriuretic peptide (NP) ligands specific to the receptors: atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP). The NP family is thought to have arisen through gene duplication during evolution and plays an essential role in cardiovascular and body fluid homeostasis. ANP and BNP bind mainly to NPR-A, while CNP binds specifically to NPR-B. Both NPR-A and NPR-B have guanylyl cyclase catalytic activity and produces intracellular secondary messenger cGMP in response to peptide-ligand binding. Consequently, the NPR-A activation results in vasodilation and inhibition of vascular smooth muscle cell proli

>cd06384 PBP1_NPR_B Ligand-binding domain of type B natriuretic peptide receptor

Probab=87.91  E-value=2  Score=38.84  Aligned_cols=110  Identities=16%  Similarity=0.160  Sum_probs=71.5

Q ss_pred             ceEeeCCCCCChHHHHHHHHHHhcCC-cceeeccc-ccc-------cchhhhhhhc-cCCccccccCCCcchhHHHHHhh
Q psy12232         89 YLIQVNPPGDILPEVIRAIILMQNIT-DAGILFDD-SFI-------FDHKYKSLLQ-NIPTRHIIAPVEDSRSVKRQLFR  158 (202)
Q Consensus        89 YLlqv~pp~~~~pe~vr~~~~~~nit-~Agi~~d~-~f~-------~~~ky~~ll~-~~p~rh~~~~~~~~~~~~~~~~~  158 (202)
                      |.+.+.|+.......+..++...+-+ .+++++++ +..       ...-.+.+-+ ++..........+..++..+|++
T Consensus       119 ~~fR~~p~~~~~~~~~~~i~~~~~w~~~vaiiy~~~~~~~~~~~~~~~~~~~~~~~~gi~v~~~~~~~~~~~d~~~~l~~  198 (399)
T cd06384         119 TTVRTGPSTTKLGEFVNHLHEHFNWTSRAALLYLDLKTDDRPHYFISEGVFLALQEENANVSAHPYHIEKNSDIIEIIQF  198 (399)
T ss_pred             ceEEecCcHHHHHHHHHHHHHhCCCcEEEEEEEecCCccCCcceEehHHHHHHHHhcCceEEEEEEeccchhhHHHHHHH
Confidence            38888787666666677788888888 57788743 222       2233333322 33222111111135788899999


Q ss_pred             cccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        159 FKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       159 ~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +|. +.-=+++.|.......++..|....+.+..|.|..+.
T Consensus       199 ik~-~~~vIi~~~~~~~~~~i~~qa~~~g~~~~~y~~i~~d  238 (399)
T cd06384         199 IKQ-NGRIVYICGPLETFLEIMLQAQREGLTPGDYVFFYLD  238 (399)
T ss_pred             Hhh-cccEEEEeCCchHHHHHHHHHHHcCCCCCcEEEEEeh
Confidence            886 5433344699899999999999999999999997543

Ligand-binding domain of type B natriuretic peptide receptor (NPR-B). NPR-B is one of three known single membrane-spanning natriuretic peptide receptors that have been identified. Natriuretic peptides are family of structurally related but genetically distinct hormones/paracrine factors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. Like NPR-A (or GC-A), NPR-B (or GC-B) is a transmembrane guanylyl cyclase, an enzyme that catalyzes the synthesis of cGMP. NPR-B is the predominant natriuretic peptide receptor in the brain. The rank of order activation of NPR-B by natriuretic peptides is CNPANPBNP. Homozygous inactivating mutations in human NPR-B cause a form of short-limbed dwarfism known as acromesomelic dysplasia type Maroteaux.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=87.27  E-value=0.32  Score=42.64  Aligned_cols=24  Identities=8%  Similarity=0.135  Sum_probs=21.4

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+|+.
T Consensus       274 l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         274 AIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHHhCCCChhhCCCHHHHhc
Confidence            568999999999999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=87.27  E-value=0.33  Score=41.94  Aligned_cols=24  Identities=21%  Similarity=0.379  Sum_probs=21.4

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||+.+|.+||++.+++.
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            668999999999999999997773

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=86.85  E-value=0.44  Score=41.68  Aligned_cols=25  Identities=12%  Similarity=0.227  Sum_probs=21.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.++|.+||..+|.+|||..+++.
T Consensus       263 ~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         263 SAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4679999999999999999887753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=86.56  E-value=0.38  Score=42.20  Aligned_cols=24  Identities=4%  Similarity=0.173  Sum_probs=21.3

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       276 ~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         276 ALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHhCCCchhccCHHHHhC
Confidence            568999999999999999998864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=86.56  E-value=0.41  Score=41.62  Aligned_cols=26  Identities=15%  Similarity=0.257  Sum_probs=22.4

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||+.+|.+||++.+++.+
T Consensus       269 ~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         269 EALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhC
Confidence            35689999999999999999987753

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=86.54  E-value=0.44  Score=45.02  Aligned_cols=26  Identities=19%  Similarity=0.198  Sum_probs=23.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||+.+|.+||++.+++.+
T Consensus       272 ~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        272 EMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHhC
Confidence            46789999999999999999998764

>cd06376 PBP1_mGluR_groupIII Ligand-binding domain of the group III metabotropic glutamate receptor

Probab=86.53  E-value=2.3  Score=39.52  Aligned_cols=109  Identities=13%  Similarity=0.244  Sum_probs=71.0

Q ss_pred             cceEeeCCCCCChHHHHHHHHHHhcCCcceeec-ccccccch--hhhhhhc---cCCcc--ccccCCCcchhHHHHHhhc
Q psy12232         88 KYLIQVNPPGDILPEVIRAIILMQNITDAGILF-DDSFIFDH--KYKSLLQ---NIPTR--HIIAPVEDSRSVKRQLFRF  159 (202)
Q Consensus        88 ~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~-d~~f~~~~--ky~~ll~---~~p~r--h~~~~~~~~~~~~~~~~~~  159 (202)
                      +|.+...|+....-.++..++...|-...++++ ++.|...-  ..+..++   .+...  -.+.-.....++..+|+++
T Consensus       147 ~~ffR~~p~d~~~~~ai~~~i~~~~w~~Vaii~~~~~yg~~~~~~~~~~~~~~g~~~v~~~~~i~~~~~~~d~~~~l~~i  226 (463)
T cd06376         147 DFFSRVVPPDSFQAQAMVDIVKALGWNYVSTLASEGNYGESGVEAFTQISREAGGVCIAQSIKIPREPRPGEFDKIIKRL  226 (463)
T ss_pred             CceEEccCCHHHHHHHHHHHHHHcCCeEEEEEEeCChHHHHHHHHHHHHHHHcCCceEEEEEecCCCCCHHHHHHHHHHH
Confidence            567777777666666677788888988889998 45454111  0111111   11111  1111122357888999999


Q ss_pred             cc-CceeeeeeecchhhHHHHHhhhhhhhcccccceeEE
Q psy12232        160 KD-LDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHA  197 (202)
Q Consensus       160 ~~-~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~  197 (202)
                      ++ -+..-.++.|.......++..|...++.| +|-|..
T Consensus       227 k~~~~~~vIvl~~~~~~~~~ll~~a~~~~~~g-~~~wig  264 (463)
T cd06376         227 LETPNARAVIIFANEDDIRRVLEAAKRANQVG-HFLWVG  264 (463)
T ss_pred             hccCCCeEEEEecChHHHHHHHHHHHhcCCcC-ceEEEE
Confidence            76 46666788899999999999999888888 477754

Ligand-binding domain of the group III metabotropic glutamate receptor, a family which contains mGlu4R, mGluR6R, mGluR7, and mGluR8; all of which inhibit adenylyl cyclase. The metabotropic glutamate receptor is a member of the family C of G-protein-coupled receptors that transduce extracellular signals into G-protein activation and ultimately into intracellular responses. The mGluRs are classified into three groups which comprise eight subtypes.

>cd06366 PBP1_GABAb_receptor Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA)

Probab=85.85  E-value=4.6  Score=35.28  Aligned_cols=112  Identities=13%  Similarity=0.204  Sum_probs=73.4

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeeccc-ccccc--hhhhhhhcc--CCccccccCCC---cchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDD-SFIFD--HKYKSLLQN--IPTRHIIAPVE---DSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~-~f~~~--~ky~~ll~~--~p~rh~~~~~~---~~~~~~~~~~  157 (202)
                      ..+|.+...|+.......+..++...+.+..++++.+ .|..+  ...+..++.  +...... .+.   ...++..++.
T Consensus       108 ~~~~~~r~~p~~~~~~~a~~~~~~~~~~~~v~ii~~~~~~g~~~~~~~~~~~~~~g~~v~~~~-~~~~~~~~~d~~~~l~  186 (350)
T cd06366         108 QYPYFFRTTPSDSSQNPAIAALLKKFGWRRVATIYEDDDYGSGGLPDLVDALQEAGIEISYRA-AFPPSANDDDITDALK  186 (350)
T ss_pred             cCCceEEcccchHhHHHHHHHHHHHCCCcEEEEEEEcCcccchhHHHHHHHHHHcCCEEEEEe-ccCCCCChhHHHHHHH
Confidence            3457777777666666666667777787877777753 33311  122333331  2111111 111   1478999999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ++++.+--=+++.+.......++.+|...++.+++|.|...
T Consensus       187 ~i~~~~~dvvi~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~  227 (350)
T cd06366         187 KLKEKDSRVIVVHFSPDLARRVFCEAYKLGMMGKGYVWILT  227 (350)
T ss_pred             HHhcCCCeEEEEECChHHHHHHHHHHHHcCCcCCCEEEEEC
Confidence            99876655567788889999999999999999999988753

Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). GABA is the major inhibitory neurotransmitter in the mammalian CNS and, like glutamate and other transmitters, acts via both ligand gated ion channels (GABAa receptors) and G-protein coupled receptors (GABAb). GABAa receptors are members of the ionotropic receptor superfamily which includes alpha-adrenergic and glycine receptors. The GABAb receptor is a member of a receptor superfamily which includes the mGlu receptors. The GABAb receptor is coupled to G alpha_i proteins, and activation causes a decrease in calcium, an increase in potassium membrane conductance, and inhibition of cAMP formation. The response is thus inhibitory and leads to hyperpolarization and decreased neurotransmitter release, for example.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=85.63  E-value=0.46  Score=41.67  Aligned_cols=25  Identities=8%  Similarity=0.141  Sum_probs=22.1

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      +-+++.+||+.+|.+||++.+++.+
T Consensus       273 ~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         273 AVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5589999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=84.77  E-value=0.72  Score=40.09  Aligned_cols=24  Identities=8%  Similarity=0.217  Sum_probs=21.5

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLV   25 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv   25 (202)
                      .+.+++.+||+.+|.+|||+.+++
T Consensus       267 ~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         267 LALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHh
Confidence            367899999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=84.18  E-value=0.66  Score=40.84  Aligned_cols=25  Identities=8%  Similarity=0.085  Sum_probs=22.1

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      +.+++.+||..+|.+|||..+++.+
T Consensus       291 ~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         291 ARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHhccCcccCCCHHHHhcC
Confidence            5689999999999999999988753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=83.77  E-value=0.75  Score=42.94  Aligned_cols=25  Identities=24%  Similarity=0.181  Sum_probs=22.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+||++.+++.
T Consensus       298 ~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        298 GMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHh
Confidence            4789999999999999999999864

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=83.35  E-value=0.7  Score=40.53  Aligned_cols=25  Identities=8%  Similarity=0.098  Sum_probs=22.3

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      +.+++.+|+..+|.+|||..+++.+
T Consensus       287 ~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         287 ARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHHhcCCchhcCCHHHHhcC
Confidence            5789999999999999999988754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06352 PBP1_NPR_GC_like Ligand-binding domain of membrane guanylyl-cyclase receptors

Probab=82.51  E-value=5.1  Score=35.58  Aligned_cols=111  Identities=18%  Similarity=0.258  Sum_probs=69.7

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeeccccc--ccc--hhhhhhhc--cCCccccccCCC-c--chhHHHHH
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSF--IFD--HKYKSLLQ--NIPTRHIIAPVE-D--SRSVKRQL  156 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f--~~~--~ky~~ll~--~~p~rh~~~~~~-~--~~~~~~~~  156 (202)
                      ..+|++.+.|+....-..+..++...+...+++++++..  .-.  .-.+..++  .+....... +. .  ..++..+|
T Consensus       110 ~~~~~fr~~~~~~~~~~a~~~~l~~~~~~~v~ii~~~~~~~g~~~~~~~~~~~~~~G~~v~~~~~-~~~~~~~~d~~~~l  188 (389)
T cd06352         110 EYPTLTRTLPPARKLGEAVLALLRWFNWHVAVVVYSDDSENCFFTLEALEAALREFNLTVSHVVF-MEDNSGAEDLLEIL  188 (389)
T ss_pred             cCCceeecCCcHHHHHHHHHHHHHHcCceEEEEEEecCCccHHHHHHHHHHHHHhcCCeEEEEEE-ecCCccchhHHHHH
Confidence            346778877776554444555566777778788886654  311  11112222  111111100 11 1  46788888


Q ss_pred             hhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        157 FRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       157 ~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ++++..+ --+++.+.......+|..|....+++.+|-|...
T Consensus       189 ~~i~~~~-~vii~~~~~~~~~~~l~q~~~~g~~~~~~~~i~~  229 (389)
T cd06352         189 QDIKRRS-RIIIMCGSSEDVRELLLAAHDLGLTSGDYVFILI  229 (389)
T ss_pred             HHhhhcc-eEEEEECCHHHHHHHHHHHHHcCCCCCcEEEEEE
Confidence            8888776 4466777778999999999999999888888753

Ligand-binding domain of membrane guanylyl-cyclase receptors. Membrane guanylyl cyclases (GC) have a single membrane-spanning region and are activated by endogenous and exogenous peptides. This family can be divided into three major subfamilies: the natriuretic peptide receptors (NPRs), sensory organ-specific membrane GCs, and the enterotoxin/guanylin receptors. The binding of peptide ligands to the receptor results in the activation of the cytosolic catalytic domain. Three types of NPRs have been cloned from mammalian tissues: NPR-A/GC-A, NPR-B/ GC-B, and NPR-C. In addition, two of the GCs, GC-D and GC-G, appear to be pseudogenes in humans. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are produced in the heart, and both bind to the NPR-A. NPR-C, also termed the clearance receptor, binds each of the natriuretic peptides and can alter circulating levels of these peptides. The l

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=81.49  E-value=0.99  Score=39.64  Aligned_cols=24  Identities=8%  Similarity=0.070  Sum_probs=21.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +-+++.+||+.+|.+|||+.+++.
T Consensus       287 ~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         287 ARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhc
Confidence            458999999999999999998874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd04509 PBP1_ABC_transporter_GCPR_C_like Family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems

Probab=80.91  E-value=8.8  Score=31.35  Aligned_cols=112  Identities=17%  Similarity=0.157  Sum_probs=69.2

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccc---cchhhhhhhcc--CCccccccCCCcchhHHHHHhhccc
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFI---FDHKYKSLLQN--IPTRHIIAPVEDSRSVKRQLFRFKD  161 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~---~~~ky~~ll~~--~p~rh~~~~~~~~~~~~~~~~~~~~  161 (202)
                      .+|...+.|+....-..+...+...+....++++.+.-.   +-.-++..++.  +.......--.+.++...+++++++
T Consensus       110 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~v~iv~~~~~~~~~~~~~~~~~~~~~g~~i~~~~~~~~~~~~~~~~~~~l~~  189 (299)
T cd04509         110 YPYLFRTGPSDEQQAEALADYIKEYNWKKVAILYDDDSYGRGLLEAFKAAFKKKGGTVVGEEYYPLGTTDFTSLLQKLKA  189 (299)
T ss_pred             CCCEEEecCCcHHHHHHHHHHHHHcCCcEEEEEecCchHHHHHHHHHHHHHHHcCCEEEEEecCCCCCccHHHHHHHHHh
Confidence            457788877766666666677777888887888776531   22334444442  2221111111123567777777766


Q ss_pred             CceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        162 LDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       162 ~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ....=.|+.+.......++.++....+. .++.|...+
T Consensus       190 ~~~~~v~~~~~~~~~~~~~~~~~~~g~~-~~~~~i~~~  226 (299)
T cd04509         190 AKPDVIVLCGSGEDAATILKQAAEAGLT-GGYPILGIT  226 (299)
T ss_pred             cCCCEEEEcccchHHHHHHHHHHHcCCC-CCCcEEecc
Confidence            5433346666668888999999988777 678887654

This CD includes members of the family C of G-protein coupled receptors and their close homologs, the type I periplasmic-binding proteins of ATP-binding cassette transporter-like systems. The family C GPCR includes glutamate/glycine-gated ion channels such as the NMDA receptor, G-protein-coupled receptors, metabotropic glutamate, GABA-B, calcium sensing, phermone receptors, and atrial natriuretic peptide-guanylate cyclase receptors. The glutamate receptors that form cation-selective ion channels, iGluR, can be classified into three different subgroups according to their binding-affinity for the agonists NMDA (N-methyl-D-asparate), AMPA (alpha-amino-3-dihydro-5-methyl-3-oxo-4-isoxazolepropionic acid), and kainate. L-glutamate is a major neurotransmitter in the brain of vertebrates and acts th

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	202
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/48 (60%), Positives = 33/48 (68%), Gaps = 4/48 (8%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL 51
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPL 332

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/48 (60%), Positives = 33/48 (68%), Gaps = 4/48 (8%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL 51
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPL 332

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/48 (56%), Positives = 33/48 (68%), Gaps = 4/48 (8%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL 51
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N    QEYL+L  PL
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN----QEYLDLSMPL 325

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 26/48 (54%), Positives = 32/48 (66%), Gaps = 4/48 (8%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL 51
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N    QE L+L  PL
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN----QEXLDLSMPL 325

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 335 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 281 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 315

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 23/35 (65%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 278 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 312

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/38 (55%), Positives = 28/38 (73%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLG 41
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+ +G
Sbjct: 323 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 22/35 (62%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T N+
Sbjct: 276 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNQ 310

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 316

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 275 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 309

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 282 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 316

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 274 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 308

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 271 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 305

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/35 (57%), Positives = 26/35 (74%)
Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 301

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	202
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-09
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-09
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-09
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-08
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-08
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-08
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-08
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-08
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-08
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-08
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-08
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-08
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-07
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-07
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-07
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-07
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-07
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-07
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-07
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-07
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-07
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-06
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-06
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-06
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-05
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-05
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-05
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-05
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-05
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-04
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-04

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 65.0 bits (159), Expect = 7e-13
 Identities = 29/48 (60%), Positives = 33/48 (68%), Gaps = 4/48 (8%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPL 51
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE    EYL+L  PL
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE----EYLDLSQPL 332

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 1/60 (1%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+N+ +G  +        D P +     N
Sbjct: 323 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHD-YDIPTTENLYFN 381

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 59.7 bits (145), Expect = 4e-11
 Identities = 11/58 (18%), Positives = 23/58 (39%), Gaps = 7/58 (12%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDE 61
           Y +M  CW +   +RP F  ++ +++             + +    P+   P   E+E
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------DPDVINTALPIEYGPLVEEEE 366

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 58.9 bits (143), Expect = 9e-11
 Identities = 11/58 (18%), Positives = 23/58 (39%), Gaps = 7/58 (12%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDE 61
           Y +M  CW +   +RP F  ++ +++             + +    P+   P   E+E
Sbjct: 275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDP-------DVINTALPIEYGPLVEEEE 325

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 58.2 bits (141), Expect = 2e-10
 Identities = 16/50 (32%), Positives = 25/50 (50%), Gaps = 4/50 (8%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLD 53
           YE+M  CW   A  RP F +LVS++  I +    E     Y+ + A  ++
Sbjct: 326 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE----HYVHVNATYVN 371

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 56.9 bits (138), Expect = 5e-10
 Identities = 12/44 (27%), Positives = 25/44 (56%), Gaps = 4/44 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLEL 47
           Y++M+ CW    + RP F  LV ++++I++    +     Y++L
Sbjct: 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD----HYVQL 297

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 56.2 bits (136), Expect = 8e-10
 Identities = 23/35 (65%), Positives = 26/35 (74%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y +MRDCW  V S+RP F QLV  LDRILT+T NE
Sbjct: 335 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 55.7 bits (135), Expect = 9e-10
 Identities = 15/36 (41%), Positives = 19/36 (52%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           Y+LMR CW     +RP F  L S L+   T T  +Y
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.7 bits (135), Expect = 1e-09
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y+ M DCW    S+RP F +LV  L  +L   A +
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 55.3 bits (134), Expect = 1e-09
 Identities = 14/36 (38%), Positives = 20/36 (55%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           YE+M  CW   A  RP F +LVS++  I +    E+
Sbjct: 262 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 14/39 (35%), Positives = 18/39 (46%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQ 42
           Y +M  CW     ERP F  + S LD   T T ++Y   
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 55.3 bits (134), Expect = 2e-09
 Identities = 10/35 (28%), Positives = 21/35 (60%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y++M+ CW     +RP F Q+V  +++ ++ + N 
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 12/44 (27%), Positives = 19/44 (43%), Gaps = 4/44 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLEL 47
           Y +M+ CW++ + +RP F  L S L   L           Y  +
Sbjct: 305 YIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE----AMYQNV 344

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 18/59 (30%), Positives = 28/59 (47%), Gaps = 2/59 (3%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDES 62
           Y+LMR CW     ERP F Q++  L+R+L      Y+     E +        S+E+ +
Sbjct: 271 YDLMRQCWREKPYERPSFAQILVSLNRMLE-ERKTYVNTTLYE-KFTYAGIDCSAEEAA 327

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 54.3 bits (131), Expect = 3e-09
 Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 6/62 (9%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +M  CW   A  RP+F +L+ +  ++          Q YL ++       PS  D + 
Sbjct: 249 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP------QRYLVIQGDERMHLPSPTDSNF 302

Query: 64  DD 65
             
Sbjct: 303 YR 304

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 53.9 bits (130), Expect = 4e-09
 Identities = 16/49 (32%), Positives = 24/49 (48%), Gaps = 2/49 (4%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQE--YLELEAP 50
           Y+LM  CWS    +RP F  L  +L+ IL   +     Q+  Y+ +E  
Sbjct: 269 YDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIERA 317

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 54.2 bits (130), Expect = 5e-09
 Identities = 14/44 (31%), Positives = 23/44 (52%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLEL 47
           Y LM DCW Y   +RP+F+ +  ++       A++  G   LE+
Sbjct: 569 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 53.7 bits (129), Expect = 7e-09
 Identities = 13/36 (36%), Positives = 18/36 (50%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           ++LM  CW     ERP F  L + L+   T T  +Y
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 13/46 (28%), Positives = 22/46 (47%), Gaps = 6/46 (13%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEA 49
           Y +MR CW   A  RP+F +L+ +  ++          Q YL ++ 
Sbjct: 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARDP------QRYLVIQG 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 52.7 bits (127), Expect = 1e-08
 Identities = 11/36 (30%), Positives = 16/36 (44%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           Y +M+ CW+   + RP F Q+ S L         E 
Sbjct: 297 YSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 52.6 bits (127), Expect = 1e-08
 Identities = 9/30 (30%), Positives = 15/30 (50%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y LM  CW     +RP F  +   L++++ 
Sbjct: 282 YRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 13/36 (36%), Positives = 18/36 (50%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           ++LM  CW     ERP F  L + L+   T T  +Y
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 52.2 bits (126), Expect = 2e-08
 Identities = 11/36 (30%), Positives = 19/36 (52%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           YELMR CW +  S+RP F ++    + +   ++   
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 52.0 bits (125), Expect = 2e-08
 Identities = 11/36 (30%), Positives = 19/36 (52%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           +ELM+ CW+    +RP F  L  +LD + + +    
Sbjct: 274 HELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 51.5 bits (124), Expect = 3e-08
 Identities = 12/41 (29%), Positives = 21/41 (51%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEY 44
           Y LM DCW Y   +RP+F+ +  ++       A++  G  +
Sbjct: 243 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 51.2 bits (123), Expect = 4e-08
 Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 12/75 (16%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLL------DTPPS 57
           Y +M  CW    + RP F +L ++  R+            YL ++            P  
Sbjct: 247 YMVMVKCWMIDENIRPTFKELANEFTRMARDP------PRYLVIKRESGPGIAPGPEPHG 300

Query: 58  SEDESNDDEETCAYL 72
             ++  ++ E    L
Sbjct: 301 LTNKKLEEVELEPEL 315

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 51.3 bits (123), Expect = 4e-08
 Identities = 11/36 (30%), Positives = 19/36 (52%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           YELMR CW +  S+RP F ++    + +   ++   
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 50.7 bits (122), Expect = 4e-08
 Identities = 14/30 (46%), Positives = 21/30 (70%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           YE+M++CW   A+ RP F+QL  +L+ I T
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 50.7 bits (122), Expect = 5e-08
 Identities = 12/41 (29%), Positives = 17/41 (41%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEY 44
           Y+LM  CW+Y    RP F  +  +L        NE     +
Sbjct: 250 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 50.8 bits (122), Expect = 5e-08
 Identities = 9/44 (20%), Positives = 17/44 (38%), Gaps = 6/44 (13%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLEL 47
           Y +MR CW     +R     + ++L  +            YL++
Sbjct: 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQAP------PVYLDV 327

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 50.7 bits (122), Expect = 5e-08
 Identities = 13/36 (36%), Positives = 18/36 (50%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           Y LM  CW Y  S+RP F +LV  L  +  +  +  
Sbjct: 244 YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 50.8 bits (122), Expect = 6e-08
 Identities = 13/52 (25%), Positives = 25/52 (48%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTP 55
           Y+LM  CW    + RP+F  +VS LD+++    +     ++    +  L + 
Sbjct: 280 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPST 331

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 50.8 bits (122), Expect = 6e-08
 Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 8/61 (13%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           +ELMR CW Y    RP F++++S +   +           + E+     +     E E  
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEME--------PGFREVSFYYSEENKLPEPEEL 321

Query: 64  D 64
           D
Sbjct: 322 D 322

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 50.3 bits (121), Expect = 6e-08
 Identities = 7/32 (21%), Positives = 13/32 (40%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVT 35
           Y++M  CW     +R    ++   L  +   T
Sbjct: 265 YDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 12/36 (33%), Positives = 17/36 (47%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           Y LM++CW   AS RP F  L+  L  +      + 
Sbjct: 281 YHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 12/29 (41%), Positives = 17/29 (58%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y LMR CWS + ++RP F  +   L R+ 
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMC 334

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 11/30 (36%), Positives = 17/30 (56%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           YE+M  CW     +RP F  L  +L+++L 
Sbjct: 279 YEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 49.5 bits (119), Expect = 1e-07
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
           Y LM  CW+Y  S RP F +L ++L  IL     +
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 50.0 bits (120), Expect = 1e-07
 Identities = 13/30 (43%), Positives = 21/30 (70%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y++M++CW   A+ RP F+QL  +L+ I T
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 11/33 (33%), Positives = 19/33 (57%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTA 36
           Y +M +CW+   ++RP F  L  ++D+I    A
Sbjct: 293 YMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.5 bits (118), Expect = 1e-07
 Identities = 14/33 (42%), Positives = 18/33 (54%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTA 36
           Y+ M DCW    S+RP F +LV  L  +L   A
Sbjct: 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 48.8 bits (117), Expect = 2e-07
 Identities = 13/36 (36%), Positives = 21/36 (58%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY 39
           ++LM DCW    ++RP F Q+VS LD ++    +  
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 48.4 bits (116), Expect = 3e-07
 Identities = 11/29 (37%), Positives = 16/29 (55%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y +M  CW   A ERP F  L+S +  ++
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVM 279

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 49.1 bits (117), Expect = 3e-07
 Identities = 14/30 (46%), Positives = 18/30 (60%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y LM  CW+Y  S RP F +L ++L  IL 
Sbjct: 622 YSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 48.5 bits (116), Expect = 3e-07
 Identities = 11/29 (37%), Positives = 16/29 (55%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y+LMR CW +  S R  F  L+   + +L
Sbjct: 273 YQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 48.0 bits (115), Expect = 4e-07
 Identities = 10/30 (33%), Positives = 16/30 (53%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y++M  CW     +RP F +L+ +L  I  
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 48.0 bits (115), Expect = 5e-07
 Identities = 10/29 (34%), Positives = 18/29 (62%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y++M  CW  +  +RP F QL+S ++ + 
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 48.1 bits (115), Expect = 5e-07
 Identities = 14/29 (48%), Positives = 21/29 (72%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           Y+LM DCW    + RP+F Q+VS LD+++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 47.7 bits (114), Expect = 6e-07
 Identities = 8/30 (26%), Positives = 14/30 (46%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
             L+ +C  Y    RP F  ++  L+ + T
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 47.7 bits (114), Expect = 7e-07
 Identities = 10/30 (33%), Positives = 18/30 (60%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILT 33
           Y +M +CW+   ++RP F  L  ++D+I  
Sbjct: 262 YMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 12/57 (21%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEY-LGQEYLELEAPLLDTPPSSE 59
           + +   C      +RP F++L   L+ +    A    LG +  +L+    +T    E
Sbjct: 253 FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGE 309

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 45.7 bits (109), Expect = 3e-06
 Identities = 11/26 (42%), Positives = 15/26 (57%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLD 29
           Y LM +CW+   S RP F  + S+L 
Sbjct: 260 YALMIECWNEFPSRRPRFKDIHSRLR 285

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 45.7 bits (109), Expect = 3e-06
 Identities = 10/29 (34%), Positives = 15/29 (51%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
           + LM  CW+Y   +RP F  +  +L  I 
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 45.3 bits (108), Expect = 3e-06
 Identities = 9/28 (32%), Positives = 14/28 (50%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRI 31
           Y +M  CW++   +RP F+ L   L   
Sbjct: 255 YNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 43.1 bits (102), Expect = 2e-05
 Identities = 7/29 (24%), Positives = 16/29 (55%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
             LM +C      ERP F +++++++ + 
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAEIEELA 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 8/29 (27%), Positives = 18/29 (62%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRIL 32
            +++  CW++   ERP F +L+  L+++ 
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 42.3 bits (100), Expect = 4e-05
 Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 5/64 (7%)

Query: 5   ELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESND 64
            LM  CWS   S+RP   ++V  +  ++      Y       L+ P   + P  ED   +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLM-----RYFPGADEPLQYPCQHSLPPGEDGRVE 289

Query: 65  DEET 68
               
Sbjct: 290 PYVD 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 41.1 bits (97), Expect = 9e-05
 Identities = 10/28 (35%), Positives = 15/28 (53%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRI 31
            +LM DCW+     RP F  ++ +L  I
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 6/29 (20%), Positives = 14/29 (48%)

Query: 5   ELMRDCWSYVASERPEFIQLVSKLDRILT 33
            ++  CW+    +RP F  ++  L  ++ 
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 38.8 bits (91), Expect = 6e-04
 Identities = 8/27 (29%), Positives = 14/27 (51%)

Query: 5   ELMRDCWSYVASERPEFIQLVSKLDRI 31
            ++  CWS    +RP F  +V +L  +
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSEL 287

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	202
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	97.72
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	97.29
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	96.69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	96.47
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	96.43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	96.41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	96.27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	96.1
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	95.75
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	95.65
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	95.49
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	95.41
3o21_A	389	Glutamate receptor 3; periplasmatic binding protei	95.37
3saj_A	384	Glutamate receptor 1; rossman fold, ION channel, m	94.84
3h6g_A	395	Glutamate receptor, ionotropic kainate 2; membrane	94.81
4gpa_A	389	Glutamate receptor 4; PBP fold, ligand-gated ION c	93.87
3hsy_A	376	Glutamate receptor 2; ligand-gated ION channel, sy	93.86
2dyl_A	318	Dual specificity mitogen-activated protein kinase	93.59
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	93.53
3qel_B	364	Glutamate [NMDA] receptor subunit epsilon-2; ION c	93.48
3qek_A	384	NMDA glutamate receptor subunit; amino terminal do	93.3
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	93.08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	92.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	92.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	92.32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	92.02
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	91.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	91.85
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	91.51
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	91.43
3kg2_A	823	Glutamate receptor 2; ION channel, membrane protei	91.4
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	91.24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	91.03
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	90.73
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	90.7
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	90.55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	90.28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	90.24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	90.23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	90.21
3om0_A	393	Glutamate receptor, ionotropic kainate 5; membrane	90.1
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	89.78
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	89.67
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	89.26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	89.2
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	89.15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	89.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	88.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	88.85
1dp4_A	435	Atrial natriuretic peptide receptor A; periplasmic	88.77
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	88.46
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	88.1
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	88.09
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	87.77
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	87.59
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	87.48
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	87.39
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	87.37
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	87.34
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	87.26
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	87.08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	87.07
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	86.77
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	86.49
3ork_A	311	Serine/threonine protein kinase; structural genomi	86.26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	86.21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	85.54
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	85.28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	85.05
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	84.83
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	84.8
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	84.7
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	84.69
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	84.68
1jdp_A	441	NPR-C, atrial natriuretic peptide clearance recept	84.42
4f11_A	433	Gamma-aminobutyric acid type B receptor subunit 2;	83.82
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	83.8
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	83.43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	83.25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	83.07
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	82.99
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	82.79
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	82.18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	82.07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	81.45
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	81.02

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=97.72  E-value=2e-05  Score=68.94  Aligned_cols=94  Identities=26%  Similarity=0.284  Sum_probs=34.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhccccc-ccccccCCCCCCCCCCCCCCCCCCchhhHhhhhhhhhhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYL-GQEYLELEAPLLDTPPSSEDESNDDEETCAYLLESVIRIS   80 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~~~~-~~~Yldls~p~~~~sps~~d~~~~~~~t~~~~lesI~~Wr   80 (202)
                      .+.++|.+||+.+|.+||++.++++.|+.++..+..... ...-...+.....  .+..+..  ...+...|++++    
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~w~~~~----  349 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLD--QSNVDIT--TFRTTGDWLNGV----  349 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGGGSBCCC----CCCEEC---------------------------
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccccccccCCCCCCcccccC--CCCcccc--CCCCHHHHHHhc----
Confidence            478999999999999999999999999999987654221 0000000000000  0111111  113445566554    


Q ss_pred             ccCcccccceEeeCCCCCChHHHHHHH
Q psy12232         81 NLDGEQMKYLIQVNPPGDILPEVIRAI  107 (202)
Q Consensus        81 ~l~~~~~~YLlqv~pp~~~~pe~vr~~  107 (202)
                          ...+|.-.|+..|....+.|..|
T Consensus       350 ----~~~~~~~~~~~~~~~~~~~~~~~  372 (373)
T 2qol_A          350 ----WTAHCKEIFTGVEYSSCDTIAKI  372 (373)
T ss_dssp             ---------------------------
T ss_pred             ----cchHHHHHHHhcCCCcHHHHhcc
Confidence                36688888888887777766543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=97.29  E-value=8e-05  Score=63.18  Aligned_cols=36  Identities=25%  Similarity=0.599  Sum_probs=32.5

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+.+++.+||+.+|.+||++.+++..|+.+...+..
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~  282 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhh
Confidence            478999999999999999999999999999887653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=96.69  E-value=0.0016  Score=54.62  Aligned_cols=35  Identities=26%  Similarity=0.516  Sum_probs=31.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+.+++.+||..+|.+|||+.++++.|+.+.....
T Consensus       232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            46799999999999999999999999998876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=96.47  E-value=0.0016  Score=54.14  Aligned_cols=35  Identities=23%  Similarity=0.399  Sum_probs=31.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus       251 ~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          251 SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            47899999999999999999999999998876554

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=96.43  E-value=0.0022  Score=55.08  Aligned_cols=35  Identities=17%  Similarity=0.084  Sum_probs=31.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      .+.++|..||..+|.+||+|.+|++.|+.++....
T Consensus       298 ~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          298 EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            47899999999999999999999999999998654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=96.41  E-value=0.0015  Score=55.07  Aligned_cols=36  Identities=25%  Similarity=0.551  Sum_probs=32.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+.+++.+||..+|.+|||+.++++.|+.+...+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~  280 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR  280 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            467899999999999999999999999999887653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=96.27  E-value=0.0024  Score=54.28  Aligned_cols=36  Identities=28%  Similarity=0.660  Sum_probs=32.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+.+++.+||..+|.+||++.+++..|+++...+..
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  282 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence            478999999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=96.10  E-value=0.0033  Score=54.55  Aligned_cols=36  Identities=56%  Similarity=1.001  Sum_probs=32.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+.+++.+||+.+|.+|||+.++++.|++++.....
T Consensus       321 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            478999999999999999999999999999876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=95.75  E-value=0.0058  Score=51.24  Aligned_cols=36  Identities=39%  Similarity=0.806  Sum_probs=32.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+.+++.+||..+|.+|||+.+++..|+.++.....
T Consensus       269 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          269 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            467999999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=95.65  E-value=0.0085  Score=50.42  Aligned_cols=34  Identities=12%  Similarity=0.122  Sum_probs=30.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVT   35 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~   35 (202)
                      .+.+++..||..+|.+||++.+|++.|+.++...
T Consensus       250 ~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          250 EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            4678999999999999999999999999887754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=95.49  E-value=0.0077  Score=49.83  Aligned_cols=34  Identities=21%  Similarity=0.245  Sum_probs=30.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      +.+++.+||+.+|.+|||+.++++.|..+.....
T Consensus       278 ~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          278 FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            6789999999999999999999999998877543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=95.41  E-value=0.01  Score=54.26  Aligned_cols=34  Identities=12%  Similarity=0.236  Sum_probs=31.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhh
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVT   35 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~   35 (202)
                      ++.++|..||..+|.+||++.+|++.|+.++...
T Consensus       247 ~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          247 EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            4789999999999999999999999999998743

>3o21_A Glutamate receptor 3; periplasmatic binding protein, oligomerization, membrane, TR protein; HET: NAG; 2.20A {Rattus norvegicus} PDB: 3p3w_A

Probab=95.37  E-value=0.085  Score=45.85  Aligned_cols=110  Identities=16%  Similarity=0.267  Sum_probs=78.5

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc--hhhhhhhc--c--CCccccccCCCcchhHHHHHhhc
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD--HKYKSLLQ--N--IPTRHIIAPVEDSRSVKRQLFRF  159 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~--~ky~~ll~--~--~p~rh~~~~~~~~~~~~~~~~~~  159 (202)
                      ..+|...+.|.   ...++..++...|.+..++++|+.|...  ...+..++  +  +..+..+. ..+..++..+|.++
T Consensus       106 ~~~~~~~~~p~---~~~a~~~~~~~~gw~~vaii~d~~~g~~~~~~~~~~~~~~g~~v~~~~~~~-~~~~~d~~~~l~~i  181 (389)
T 3o21_A          106 DVQFVIQMRPA---LKGAILSLLSYYKWEKFVYLYDTERGFSVLQAIMEAAVQNNWQVTARSVGN-IKDVQEFRRIIEEM  181 (389)
T ss_dssp             CCSSEEECSCC---SHHHHHHHHHHHTCCEEEEEECSTTCSHHHHHHHHHHHHTTCEEEEEECTT-CCCTHHHHHHHHHH
T ss_pred             CCceEEEEccC---HHHHHHHHHHhCCCCEEEEEEcCcHHHHHHHHHHHHhhcCCCeEEEEEecC-CCCcHHHHHHHHHH
Confidence            45677766654   4566777788899999999998877531  11222222  1  22222221 12345899999999


Q ss_pred             ccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        160 KDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       160 ~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      ++.+..-+|+.|..+....++..|....+.++.|.|..-+
T Consensus       182 k~~~~~vii~~~~~~~~~~i~~qa~~~g~~~~~~~~i~~~  221 (389)
T 3o21_A          182 DRRQEKRYLIDCEVERINTILEQVVILGKHSRGYHYMLAN  221 (389)
T ss_dssp             HTTTCCEEEEESCHHHHHHHHHHHHHHCSCSTTCEEEECC
T ss_pred             HhCCCeEEEEECCHHHHHHHHHHHHHcCcccCCeEEEEcc
Confidence            9999888899999999999999999999999999998643

>3saj_A Glutamate receptor 1; rossman fold, ION channel, membrane, transport protein; HET: NAG BMA MAN; 2.50A {Rattus norvegicus}

Probab=94.84  E-value=0.11  Score=44.72  Aligned_cols=111  Identities=10%  Similarity=0.061  Sum_probs=78.9

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccch--hhhhhhc--cCCccccccCCCcchhHHHHHhhccc
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDH--KYKSLLQ--NIPTRHIIAPVEDSRSVKRQLFRFKD  161 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~--ky~~ll~--~~p~rh~~~~~~~~~~~~~~~~~~~~  161 (202)
                      ..+|...+.|.   ....+..++...|.+..++++|+.|.-.-  ..+..++  ++........-.+..++..+|.+++.
T Consensus       104 ~~~~~~~~~p~---~~~a~~~~~~~~g~~~v~ii~d~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~d~~~~l~~ik~  180 (384)
T 3saj_A          104 SNQFVLQLRPE---LQEALISIIDHYKWQTFVYIYDADRGLSVLQRVLDTAAEKNWQVTAVNILTTTEEGYRMLFQDLEK  180 (384)
T ss_dssp             CCTTEEECSCC---CHHHHHHHHHHTTCCEEEEEECSTTCSHHHHHHHHHHHHHTCEEEEEEGGGCCHHHHHHTTTTCCS
T ss_pred             ccCceEEeccc---HHHHHHHHHHHCCCcEEEEEEeCchhHHHHHHHHHHhhhcCceEEEEEeccCCchhHHHHHHHHhc
Confidence            45677777654   45667777888999999999988775221  1222222  12111111101135679999999999


Q ss_pred             CceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        162 LDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       162 ~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      .+..-+|+.|.......++..|....+.++.|.|..-.
T Consensus       181 ~~~~vii~~~~~~~~~~~~~qa~~~g~~~~~~~~i~~~  218 (384)
T 3saj_A          181 KKERLVVVDCESERLNAILGQIVKLEKNGIGYHYILAN  218 (384)
T ss_dssp             CSEEEEEEECCGGGHHHHHHHHHHTCCTTCEEEEEESS
T ss_pred             cCCcEEEEEcCHHHHHHHHHHHHHcCCCCCCcEEEEEC
Confidence            99888999999999999999999999999999997643

>3h6g_A Glutamate receptor, ionotropic kainate 2; membrane protein glycoprotein, cell junction, cell membrane, glycoprotein, ION transport; HET: NAG TLA; 2.70A {Rattus norvegicus} PDB: 3h6h_A* 3qlv_C 3qlu_C* 3qlt_A* 3olz_A*

Probab=94.81  E-value=0.056  Score=46.38  Aligned_cols=114  Identities=14%  Similarity=0.117  Sum_probs=79.7

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc--hhhhhhhccCCccccccCCC-cchhHHHHHhhcccC
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD--HKYKSLLQNIPTRHIIAPVE-DSRSVKRQLFRFKDL  162 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~--~ky~~ll~~~p~rh~~~~~~-~~~~~~~~~~~~~~~  162 (202)
                      ..+|.+++.|........+..++...+.+..++++|+.|...  ...+..++..-..=+...+. +..++..+|.+++..
T Consensus       111 ~~~~~~r~~~~~~~~~~~~~~~~~~~g~~~v~ii~d~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~d~~~~l~~i~~~  190 (395)
T 3h6g_A          111 KDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRG  190 (395)
T ss_dssp             CCCSEEEEEECHHHHHHHHHHHHHHTTCSEEEEEESSTHHHHHTHHHHTGGGTSSCEEEEEECCSSGGGGHHHHHHHHHT
T ss_pred             cCceEEEecCCHHHHHHHHHHHHHHCCCeEEEEEEEChhHHHHHHHHHHhhhcCCceEEEEEeCCCchhHHHHHHHHhhc
Confidence            456777777665555666777888899999999999877522  11222222110000111122 356788999999988


Q ss_pred             ceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        163 DIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       163 d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +..-.|+.|.......++..|....+.++.|.|...+
T Consensus       191 ~~~vi~~~~~~~~~~~~~~qa~~~gl~~~~~~~i~~~  227 (395)
T 3h6g_A          191 KEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTT  227 (395)
T ss_dssp             TCCEEEEESCHHHHHHHHHHHHHTTCCSTTCEEEECC
T ss_pred             CCeEEEEECCHHHHHHHHHHHHHccccCCceEEEEec
Confidence            7777899999999999999999999999999997543

>4gpa_A Glutamate receptor 4; PBP fold, ligand-gated ION channel, ION transport, transmembrane AMPA receptor regulating proteins, cornichons, ckamp44; HET: NAG; 2.25A {Rattus norvegicus}

Probab=93.87  E-value=0.23  Score=41.70  Aligned_cols=110  Identities=10%  Similarity=0.140  Sum_probs=78.0

Q ss_pred             ccccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-----cCCccccccCCCcchhHHHHHhhc
Q psy12232         85 EQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-----NIPTRHIIAPVEDSRSVKRQLFRF  159 (202)
Q Consensus        85 ~~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-----~~p~rh~~~~~~~~~~~~~~~~~~  159 (202)
                      +..+|...+.|.   ...++..++...+-+..++++++.... ...+.+++     ++-.......-....++..+|+++
T Consensus       105 ~~~~~~~~~~~~---~~~a~~~l~~~~~w~~vaii~~~d~~~-~~~~~~~~~~~~~g~~v~~~~~~~~~~~d~~~~l~~i  180 (389)
T 4gpa_A          105 GESQFVLQLRPS---LRGALLSLLDHYEWNCFVFLYDTDRGY-SILQAIMEKAGQNGWHVSAICVENFNDVSYRQLLEEL  180 (389)
T ss_dssp             SCCSSEEECSCC---CHHHHHHHHHHTTCCEEEEEECSTTCS-HHHHHHHHHHHTTTCEEEEEECTTCCHHHHHHHHHHH
T ss_pred             ccccCCccccCC---HHHHHHHHHHHcCCcEEEEEEecchhh-HHHHHHHHHHHhcCceEEEEeecCCcchhHHHHHHHh
Confidence            445566555443   235688889999999999999887542 12222222     111111111111467889999999


Q ss_pred             ccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        160 KDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       160 ~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      +.......++.+.......+|..|....+.++.|.|..-
T Consensus       181 ~~~~~~vIv~~~~~~~~~~il~~a~~~g~~~~~~~~i~~  219 (389)
T 4gpa_A          181 DRRQEKKFVIDCEIERLQNILEQIVSVGKHVKGYHYIIA  219 (389)
T ss_dssp             HHHTCCEEEEECCHHHHHHHHHHHHHHTCSBTTCEEEEC
T ss_pred             hccCCcEEEEEechhHHHHHHHHHHHhCCCCCceEEEEe
Confidence            999988999999999999999999999999999999764

>3hsy_A Glutamate receptor 2; ligand-gated ION channel, synapse, cell CELL membrane, endoplasmic reticulum, glycoprotein, ION TRA ionic channel; HET: NAG BMA; 1.75A {Rattus norvegicus} PDB: 3h5v_A* 3h5w_A 3o2j_A* 2wjw_A* 2wjx_A 3n6v_A

Probab=93.86  E-value=0.14  Score=44.03  Aligned_cols=110  Identities=9%  Similarity=0.068  Sum_probs=63.1

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc---hhhhhhhc-cC--CccccccCC--CcchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD---HKYKSLLQ-NI--PTRHIIAPV--EDSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~---~ky~~ll~-~~--p~rh~~~~~--~~~~~~~~~~~  157 (202)
                      ..+|...+.|.   ..+++..++...|.+..++++|+.|...   .-.+.+-+ ++  -.+.....-  .+..++..+|.
T Consensus        97 ~~~~~~~~~p~---~~~a~~~~~~~~gw~~vaii~d~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~~~~~d~~~~l~  173 (376)
T 3hsy_A           97 THPFVIQMRPD---LKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDETYRSLFQ  173 (376)
T ss_dssp             CCTTEEECSCC---CHHHHHHHHHHTTCCEEEEEECSTTCSHHHHHHHHHHHHHTCEEEEEECTTCC-------------
T ss_pred             cCCceEEeCcc---HHHHHHHHHHhcCCCEEEEEEeCchhHHHHHHHHHHhhhcCCeEEEEEeccccccccchhHHHHHH
Confidence            45677777543   4556677778899999999998777522   11222222 22  122222110  12467889999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      +++..+..-+|+.|.......++..|....+.++.|.|..-
T Consensus       174 ~i~~~~~~vii~~~~~~~~~~~~~qa~~~g~~~~~~~~i~~  214 (376)
T 3hsy_A          174 DLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIA  214 (376)
T ss_dssp             -------CEEEEESCHHHHHHHHHHHHHHTSSGGGCEEEEC
T ss_pred             HHhhCCCeEEEEECCHHHHHHHHHHHHHcccCCCCcEEEEc
Confidence            99998888889999999999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=93.59  E-value=0.028  Score=46.28  Aligned_cols=26  Identities=19%  Similarity=0.496  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+||++.+|+++
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhC
Confidence            36799999999999999999988754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=93.53  E-value=0.057  Score=46.98  Aligned_cols=34  Identities=12%  Similarity=0.028  Sum_probs=30.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhc
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSKLDRILTVTA   36 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~   36 (202)
                      +.+++.+||..+|.+||++.++.+.++.++....
T Consensus       279 l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~  312 (396)
T 4eut_A          279 LTPVLANILEADQEKCWGFDQFFAETSDILHRMV  312 (396)
T ss_dssp             HHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred             chHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence            5689999999999999999999999999987543

>3qel_B Glutamate [NMDA] receptor subunit epsilon-2; ION channel, allosteric modulation, phenylethanolamine, N-glycosylation, extracellular; HET: NAG BMA MAN FUC QEL; 2.60A {Rattus norvegicus} PDB: 3qem_B* 3jpw_A* 3jpy_A*

Probab=93.48  E-value=0.056  Score=47.15  Aligned_cols=113  Identities=12%  Similarity=0.127  Sum_probs=77.9

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc----c----CCccccccCCCcchhHHHHH-
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ----N----IPTRHIIAPVEDSRSVKRQL-  156 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~----~----~p~rh~~~~~~~~~~~~~~~-  156 (202)
                      +-+|.++..|+-..-..++.++++..|-+.-|+++++ +.--...+..|+    +    +.+.-++..-....++...+ 
T Consensus       109 ~~p~f~Rt~psd~~q~~ai~~ll~~fgW~~V~iI~~d-~~g~~~~~~~l~~~~~~~~ici~~~~~i~~~~~~~~~~~~l~  187 (364)
T 3qel_B          109 ESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTY-FPGYQDFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQ  187 (364)
T ss_dssp             TTCCEEESSCCHHHHHHHHHHHHHHTTCCEEEEEEES-CTTHHHHHHHHHHHHHTCSSCCEEEEEEEECTTSCSSSCHHH
T ss_pred             cCceEEEcCCChHHHHHHHHHHHHHCCCeEEEEEEeC-CccHHHHHHHHHHHhhccccceEEEEEEccCCCcccHHHHHH
Confidence            4578888888766677788899999999999999987 311011222222    1    12222221111123445566 


Q ss_pred             hhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        157 FRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       157 ~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +++++.+..-+++-|+.+.+..++..|...++.|+.|-|.+-+
T Consensus       188 ~~i~~~~a~ViIv~~~~~~~~~ll~~a~~~g~~~~~y~wI~t~  230 (364)
T 3qel_B          188 NQLKKLQSPIILLYCTKEEATYIFEVANSVGLTGYGYTWIVPS  230 (364)
T ss_dssp             HHHTTCCCSEEEEESCHHHHHHHHHHHHTTTCSSTTCEEEECH
T ss_pred             HHHHccCCcEEEEEcCHHHHHHHHHHHHHcCCCCCCeEEEEec
Confidence            5777788778888899999999999999999999999998743

>3qek_A NMDA glutamate receptor subunit; amino terminal domain, ION channel, NMDA receptor, allosteri modulation, phenylethanolamine, polyamine; HET: NAG BMA; 2.00A {Xenopus laevis} PDB: 3qel_A* 3qem_A* 3q41_A*

Probab=93.30  E-value=0.18  Score=43.11  Aligned_cols=112  Identities=13%  Similarity=0.180  Sum_probs=82.0

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccc-cccc--hhhhhhhcc---------------CCcc-------c
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDS-FIFD--HKYKSLLQN---------------IPTR-------H  141 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~-f~~~--~ky~~ll~~---------------~p~r-------h  141 (202)
                      -+|.++..|+.......+..++...+.+..++++.+. |.-+  ...+..++.               +.+.       -
T Consensus       113 ~~~~fr~~~~~~~~~~a~~~~~~~~gw~~v~ii~~d~~~G~~~~~~~~~~~~~~g~~v~~~~~~~~~~v~~~~~~~~~~~  192 (384)
T 3qek_A          113 HLSFLRTVPPYSHQALVWFEMMRLFNWNHVILIVSDDHEGRAAQKKLETLLEGKESKSKKRNYENLDQLSYDNKRGPKAD  192 (384)
T ss_dssp             CTTEEESSCCGGGHHHHHHHHHHHTTCCEEEEEEESSHHHHHHHHHHHHHHC--------------CCSCCCCCCCCEEE
T ss_pred             CCceEEecCChHHHHHHHHHHHHHcCCeEEEEEEEcCcccHHHHHHHHHHHHhccCccccccccccceeeeccccCcccc
Confidence            3788998888888888888889999999999988654 4311  233444442               1111       1


Q ss_pred             cccCC-CcchhHHHHHhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        142 IIAPV-EDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       142 ~~~~~-~~~~~~~~~~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      .+... .+..++..+|.+++.....-+++.|..+....++..|...++.|+.|-|.+-
T Consensus       193 ~v~~~~~~~~d~~~~l~~i~~~~~~vii~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~  250 (384)
T 3qek_A          193 KVLQFEPGTKNLTALLLEAKELEARVIILSASEDDATAVYKSAAMLDMTGAGYVWLVG  250 (384)
T ss_dssp             EEEEECTTCSCCHHHHHHHHTSSCCEEEEECCHHHHHHHHHHHHHTTCSSTTCEEECC
T ss_pred             eecccCCchhhHHHHHHHHHhcCCcEEEEECCHHHHHHHHHHHHHcCCccCCeEEEEe
Confidence            11111 1346788899999988888899999999999999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=93.08  E-value=0.055  Score=44.30  Aligned_cols=26  Identities=15%  Similarity=0.255  Sum_probs=23.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++++
T Consensus       239 ~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          239 PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            36799999999999999999998864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=92.95  E-value=0.03  Score=46.72  Aligned_cols=26  Identities=23%  Similarity=0.448  Sum_probs=23.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.++++.
T Consensus       261 ~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          261 SFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            46799999999999999999998753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=92.91  E-value=0.049  Score=45.02  Aligned_cols=26  Identities=12%  Similarity=0.201  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++++
T Consensus       232 ~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          232 EVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcC
Confidence            46789999999999999999988753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=92.32  E-value=0.054  Score=44.65  Aligned_cols=25  Identities=16%  Similarity=0.344  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.+++.
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHh
Confidence            3678999999999999999998865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=92.02  E-value=0.073  Score=45.07  Aligned_cols=26  Identities=12%  Similarity=0.280  Sum_probs=23.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++.+
T Consensus       249 ~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          249 DLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            46799999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=91.97  E-value=0.057  Score=45.72  Aligned_cols=26  Identities=19%  Similarity=0.360  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++++
T Consensus       300 ~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          300 EFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            36789999999999999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=91.85  E-value=0.049  Score=46.83  Aligned_cols=26  Identities=15%  Similarity=0.323  Sum_probs=22.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||+.+|.+|||+.++++.
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            36789999999999999999987653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=91.51  E-value=0.088  Score=45.96  Aligned_cols=26  Identities=12%  Similarity=0.280  Sum_probs=23.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++.+
T Consensus       296 ~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          296 DLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhhC
Confidence            46799999999999999999988754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=91.43  E-value=0.072  Score=44.14  Aligned_cols=25  Identities=24%  Similarity=0.343  Sum_probs=22.4

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+||++.+++.
T Consensus       262 ~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          262 KFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhh
Confidence            4679999999999999999998875

>3kg2_A Glutamate receptor 2; ION channel, membrane protein, cell membrane, glycoprotein, transport, membrane, postsynaptic cell membrane, editing; HET: ZK1 NAG BMA; 3.60A {Rattus norvegicus}

Probab=91.40  E-value=0.52  Score=44.41  Aligned_cols=111  Identities=8%  Similarity=0.053  Sum_probs=78.8

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccc--hhhhhhhc--cCC--ccccccCC--CcchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFD--HKYKSLLQ--NIP--TRHIIAPV--EDSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~--~ky~~ll~--~~p--~rh~~~~~--~~~~~~~~~~~  157 (202)
                      ..+|...+.|.   ...++..++...|.+..|+++|+.+...  ...+..++  ++.  .+-.+..-  .+..++..++.
T Consensus        97 ~~~~~~r~~p~---~~~a~~~l~~~~gw~~v~ii~d~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~~~~~d~~~~l~  173 (823)
T 3kg2_A           97 THPFVIQMRPD---LKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDETYRSLFQ  173 (823)
T ss_dssp             CCSSEEECSCC---CHHHHHHHHHHTTCSEEEEEECGGGCTHHHHHHHHHHHHTTCEEEEEECSSCCSSSTTTTTTTHHH
T ss_pred             CCceEEEeCCC---HHHHHHHHHHHCCCCEEEEEEeCChhHHHHHHHHHHhhccCCceEEEEeecCCCCccchhHHHHHH
Confidence            45677777766   5566778888899999999998776421  11122222  121  11111111  12567888999


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +++..+...+++.|..+....++..|....+.++.|.|..-.
T Consensus       174 ~i~~~~~~vii~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~~  215 (823)
T 3kg2_A          174 DLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIAN  215 (823)
T ss_dssp             HTTTTTCCEEEEECCHHHHHHHHHHHHHHTTTBTTCEEEECS
T ss_pred             HHHhcCCeEEEEECCHHHHHHHHHHHHHcCcCCCCeEEEEec
Confidence            999998888999999999999999999999999999997643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=91.24  E-value=0.067  Score=46.00  Aligned_cols=24  Identities=17%  Similarity=0.324  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.++++
T Consensus       310 ~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          310 FHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhc
Confidence            668999999999999999998874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=91.03  E-value=0.083  Score=44.49  Aligned_cols=25  Identities=12%  Similarity=0.113  Sum_probs=21.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||+.++++
T Consensus       309 ~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          309 EISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHHHHHhccCccccCCHHHHhh
Confidence            3568999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=90.73  E-value=0.12  Score=43.00  Aligned_cols=25  Identities=8%  Similarity=0.054  Sum_probs=22.5

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       250 ~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          250 KALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcccCHhhCCCHHHHhh
Confidence            3678999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=90.70  E-value=0.11  Score=44.18  Aligned_cols=26  Identities=19%  Similarity=0.229  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.++++.
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            46799999999999999999988753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=90.55  E-value=0.1  Score=44.94  Aligned_cols=26  Identities=8%  Similarity=0.124  Sum_probs=22.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+|+.+||..+|.+|||+.+++++
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhC
Confidence            36789999999999999999988754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=90.28  E-value=0.13  Score=43.63  Aligned_cols=26  Identities=19%  Similarity=0.225  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++++
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            36789999999999999999988763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=90.24  E-value=0.062  Score=45.34  Aligned_cols=26  Identities=15%  Similarity=0.277  Sum_probs=23.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||+.+|.+|||+.+++++
T Consensus       267 ~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          267 VAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            36789999999999999999998763

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=90.23  E-value=0.11  Score=43.57  Aligned_cols=24  Identities=8%  Similarity=0.178  Sum_probs=21.5

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||..++++
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          282 GIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhcCcCcccCCCHHHHhc
Confidence            568999999999999999998764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=90.21  E-value=0.19  Score=44.09  Aligned_cols=24  Identities=17%  Similarity=0.188  Sum_probs=20.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLV   25 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv   25 (202)
                      .+.+||.+||..+|.+||++.+++
T Consensus       339 ~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          339 PVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHH
Confidence            478999999999999999966653

>3om0_A Glutamate receptor, ionotropic kainate 5; membrane protein, ION channel; HET: NAG BMA GOL; 1.40A {Rattus norvegicus} PDB: 3om1_A* 3qlu_A* 3qlv_A

Probab=90.10  E-value=0.35  Score=41.42  Aligned_cols=105  Identities=12%  Similarity=0.162  Sum_probs=72.6

Q ss_pred             EeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchhhhhhhc-----cCCccccccCCCcchhHHHHHhhcccCcee
Q psy12232         91 IQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQ-----NIPTRHIIAPVEDSRSVKRQLFRFKDLDIV  165 (202)
Q Consensus        91 lqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~-----~~p~rh~~~~~~~~~~~~~~~~~~~~~d~~  165 (202)
                      +++.|+.....+.+..++...+.+..+++++++-- -...+.+++     .+...  .....+..++..+|.++++.+..
T Consensus       117 fr~~p~~~~~~~~~~~~~~~~g~~~vaii~~~~~~-g~~l~~~~~~~~~~g~~v~--~~~~~~~~d~~~~l~~i~~~~~~  193 (393)
T 3om0_A          117 VSLYPSNEDVSLAVSRILKSFNYPSASLICAKAEC-LLRLEELVRGFLISKETLS--VRMLDDSRDPTPLLKEIRDDKVS  193 (393)
T ss_dssp             EESSCCHHHHHHHHHHHHHHTTSCCEEEEESSTTH-HHHTHHHHHHHHHSSSCEE--EEECC-CCCSHHHHHHHHHHTCS
T ss_pred             EEecCCHHHHHHHHHHHHHhCCCcEEEEEEeCchH-HHHHHHHHHhhhccCCeEE--EEecCCCCCHHHHHHHHHhcCCe
Confidence            66666655556667778888999999999876532 112222222     11110  01112345778888899888877


Q ss_pred             eeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        166 NYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       166 n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      -+|+.|..+....++..|....+.++.|.|..-
T Consensus       194 vii~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~  226 (393)
T 3om0_A          194 TIIIDANASISHLVLRKASELGMTSAFYKYILT  226 (393)
T ss_dssp             EEEEESCHHHHHHHHHHHHHTTTTSTTCEEEEC
T ss_pred             EEEEECCHHHHHHHHHHHHHcCcccCCeEEEEe
Confidence            789999999999999999999999999999853

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=89.78  E-value=0.12  Score=43.55  Aligned_cols=24  Identities=8%  Similarity=0.087  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       248 ~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          248 AKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            568999999999999999998864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=89.67  E-value=0.16  Score=41.84  Aligned_cols=25  Identities=16%  Similarity=0.092  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.+++.
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3678999999999999999998874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=89.26  E-value=0.096  Score=44.00  Aligned_cols=25  Identities=20%  Similarity=0.417  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||+.+|.+|||..++++
T Consensus       290 ~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          290 EAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhccCccccCCHHHHhc
Confidence            3678999999999999999987763

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=89.20  E-value=0.12  Score=43.45  Aligned_cols=23  Identities=9%  Similarity=0.121  Sum_probs=21.0

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLV   25 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv   25 (202)
                      +.+++.+||..+|.+|||+.+++
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll  286 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICL  286 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHh
Confidence            67899999999999999998775

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=89.15  E-value=0.2  Score=41.70  Aligned_cols=24  Identities=8%  Similarity=0.131  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       249 ~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          249 AKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhc
Confidence            678999999999999999998864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=89.00  E-value=0.16  Score=43.34  Aligned_cols=25  Identities=20%  Similarity=0.236  Sum_probs=22.4

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3678999999999999999998875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=88.97  E-value=0.16  Score=42.77  Aligned_cols=25  Identities=12%  Similarity=0.092  Sum_probs=21.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||+.++++
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhh
Confidence            3568999999999999999987764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=88.85  E-value=0.16  Score=43.04  Aligned_cols=25  Identities=12%  Similarity=0.202  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||..++++
T Consensus       267 ~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          267 DLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhc
Confidence            3678999999999999999998764

>1dp4_A Atrial natriuretic peptide receptor A; periplasmic binding protein fold, dimer, hormone/growth FACT receptor, lyase complex; HET: NAG; 2.00A {Rattus norvegicus} SCOP: c.93.1.1 PDB: 1t34_A* 3a3k_A*

Probab=88.77  E-value=1.1  Score=38.62  Aligned_cols=111  Identities=13%  Similarity=0.134  Sum_probs=72.6

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceee------cccc-cc--cchhhhhhhc--cCCccccccCCCcchhHHHH
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGIL------FDDS-FI--FDHKYKSLLQ--NIPTRHIIAPVEDSRSVKRQ  155 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~------~d~~-f~--~~~ky~~ll~--~~p~rh~~~~~~~~~~~~~~  155 (202)
                      .+|.+...|+.......+..+++..+.+..|++      +++. |.  +..-.+.+-+  ++........-.+..++..+
T Consensus       120 ~~~~fr~~p~~~~~~~a~~~~l~~~~w~~v~ii~~~d~~~~~~~~g~~~~~~~~~~~~~~g~~v~~~~~~~~~~~d~~~~  199 (435)
T 1dp4_A          120 YALTTRTGPSHVKLGDFVTALHRRLGWEHQALVLYADRLGDDRPCFFIVEGLYMRVRERLNITVNHQEFVEGDPDHYPKL  199 (435)
T ss_dssp             STTEEECSCCHHHHHHHHHHHHHHHTCCSEEEEEEECCSSSCCHHHHHHHHHHHHHHHHHCCEEEEEEECTTCGGGHHHH
T ss_pred             cCeEEEecCcHHHHHHHHHHHHHHCCCcEEEEEEEccCCCCcchHHHHHHHHHHHHHhhcCeEEEEEEEecCchhhHHHH
Confidence            578888888766666667777888899998998      5432 22  2222223322  23222211110234667788


Q ss_pred             HhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        156 LFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       156 ~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      +++++. +..-.++.|.......++..|....+.+++|-|...
T Consensus       200 l~~i~~-~~~viv~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~  241 (435)
T 1dp4_A          200 LRAVRR-KGRVIYICSSPDAFRNLMLLALNAGLTGEDYVFFHL  241 (435)
T ss_dssp             HHHHHH-HCSEEEEESCHHHHHHHHHHHHHTTCCTTTCEEEEE
T ss_pred             HHHHHh-hCceEEEecChHHHHHHHHHHHHcCCCCCCEEEEEE
Confidence            888876 655567788888888999999988999988888764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=88.46  E-value=0.19  Score=42.90  Aligned_cols=25  Identities=12%  Similarity=0.169  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||+.++++
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3578999999999999999998764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=88.10  E-value=0.15  Score=42.96  Aligned_cols=24  Identities=13%  Similarity=0.184  Sum_probs=21.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.++++
T Consensus       293 ~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          293 ALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHc
Confidence            568999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=88.09  E-value=0.16  Score=44.53  Aligned_cols=26  Identities=12%  Similarity=0.201  Sum_probs=23.1

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+|+.+||..+|.+|||+.+++.+
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            36789999999999999999988764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=87.59  E-value=0.23  Score=42.36  Aligned_cols=24  Identities=17%  Similarity=0.313  Sum_probs=21.6

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.++++
T Consensus       290 ~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          290 ALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhc
Confidence            568999999999999999998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=87.48  E-value=0.23  Score=41.89  Aligned_cols=25  Identities=12%  Similarity=0.149  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||..+++.
T Consensus       281 ~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          281 QAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhc
Confidence            3678999999999999999988764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=87.39  E-value=0.18  Score=44.64  Aligned_cols=25  Identities=12%  Similarity=0.251  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.+++.
T Consensus       271 ~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          271 EATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHHh
Confidence            3678999999999999999998874

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=87.37  E-value=0.18  Score=43.38  Aligned_cols=24  Identities=13%  Similarity=0.207  Sum_probs=22.1

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.+++.
T Consensus       298 ~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          298 AIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            679999999999999999998874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=87.34  E-value=0.29  Score=41.99  Aligned_cols=25  Identities=12%  Similarity=0.149  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||+.++++
T Consensus       299 ~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          299 QAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhhcCCHHHHhc
Confidence            3678999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=87.26  E-value=0.22  Score=44.18  Aligned_cols=26  Identities=15%  Similarity=0.285  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      ++.+|+.+||..+|.+|||+.+++++
T Consensus       252 ~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          252 DLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            46789999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=87.08  E-value=0.17  Score=43.59  Aligned_cols=25  Identities=12%  Similarity=0.084  Sum_probs=22.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            3678999999999999999998864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=87.07  E-value=0.19  Score=42.05  Aligned_cols=24  Identities=8%  Similarity=0.129  Sum_probs=21.4

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.++++
T Consensus       258 ~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          258 GADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHcCcCcccCCCHHHHhc
Confidence            568999999999999999987764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=86.77  E-value=0.22  Score=42.09  Aligned_cols=26  Identities=4%  Similarity=0.009  Sum_probs=22.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||..+++++
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            35689999999999999999998763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=86.49  E-value=0.26  Score=41.41  Aligned_cols=24  Identities=8%  Similarity=0.115  Sum_probs=21.4

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||..++++
T Consensus       288 ~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          288 ALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhC
Confidence            568999999999999999987764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=86.26  E-value=0.27  Score=40.71  Aligned_cols=25  Identities=4%  Similarity=-0.077  Sum_probs=21.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+||+..+++.
T Consensus       249 ~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          249 DLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHHHHHHHHHhcCHhhChhhHHHHH
Confidence            3678999999999999998776553

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=86.21  E-value=0.29  Score=41.79  Aligned_cols=25  Identities=16%  Similarity=0.167  Sum_probs=21.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||..++++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            3678999999999999999988764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=85.54  E-value=0.47  Score=42.27  Aligned_cols=26  Identities=19%  Similarity=0.252  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||+.+++++
T Consensus       252 ~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          252 DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            36789999999999999999998764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=85.28  E-value=0.27  Score=42.62  Aligned_cols=24  Identities=13%  Similarity=0.156  Sum_probs=21.3

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+|+..+|.+|||..++++
T Consensus       310 ~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          310 AFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCCcccCCCHHHHhc
Confidence            568999999999999999987764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=85.05  E-value=0.43  Score=42.85  Aligned_cols=25  Identities=12%  Similarity=0.151  Sum_probs=22.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||..++++
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            3678999999999999999998875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=84.83  E-value=0.44  Score=43.36  Aligned_cols=26  Identities=12%  Similarity=0.151  Sum_probs=23.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+|+.+||..+|.+|||+.+++++
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            46789999999999999999998753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=84.80  E-value=0.29  Score=43.58  Aligned_cols=24  Identities=17%  Similarity=0.283  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.++++
T Consensus       260 ~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          260 ARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhCCHhhCCCHHHHHh
Confidence            468999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=84.70  E-value=0.36  Score=41.39  Aligned_cols=25  Identities=16%  Similarity=0.141  Sum_probs=22.2

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      +.+|+.+||..+|.+|||..+++++
T Consensus       295 ~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          295 ARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHCcCChhhCCCHHHHhCC
Confidence            5689999999999999999988753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=84.69  E-value=0.25  Score=42.50  Aligned_cols=24  Identities=8%  Similarity=0.181  Sum_probs=21.2

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||+.++++
T Consensus       305 ~~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          305 ALDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhhccCcccCCCHHHHhC
Confidence            568999999999999999987764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=84.68  E-value=0.3  Score=42.53  Aligned_cols=25  Identities=20%  Similarity=0.325  Sum_probs=21.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||..+++.
T Consensus       297 ~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          297 DAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhCCChhhCCCHHHHhc
Confidence            3678999999999999999987764

>1jdp_A NPR-C, atrial natriuretic peptide clearance receptor; hormone-receptor complex, natriuretic peptide receptor, ALLO activation, signaling protein; HET: NDG NAG; 2.00A {Homo sapiens} SCOP: c.93.1.1 PDB: 1jdn_A* 1yk0_A* 1yk1_A*

Probab=84.42  E-value=1.5  Score=37.96  Aligned_cols=112  Identities=13%  Similarity=0.168  Sum_probs=70.2

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeeccc-ccccc-----hhhhhhhc--cCCccccccCCCcchhHHHHHh
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDD-SFIFD-----HKYKSLLQ--NIPTRHIIAPVEDSRSVKRQLF  157 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~-~f~~~-----~ky~~ll~--~~p~rh~~~~~~~~~~~~~~~~  157 (202)
                      ..+|.+++.|+.......+..++...|.+..|+++++ .|.-.     ...+..++  ++-.......-.+..++..+++
T Consensus       127 ~~~~~fr~~p~~~~~~~a~~~~~~~~~w~~v~ii~~d~~~g~~~~~~~~~~~~~~~~~g~~v~~~~~~~~~~~d~~~~l~  206 (441)
T 1jdp_A          127 EYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVR  206 (441)
T ss_dssp             TTTTEEECSCCHHHHHHHHHHHHHHHTCCEEEEEEECCSSSCHHHHHHHHHHHHHHHHTCEEEEEEECTTSCCCHHHHHH
T ss_pred             cCCceEEecCcHHHHHHHHHHHHHhcCCcEEEEEEEcCCcccchHHHHHHHHHHHHhcCcEEEEEEecCCcccCHHHHHH
Confidence            4568888888766666667778888899988888854 33321     11222333  2211111100012234666677


Q ss_pred             hcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        158 RFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       158 ~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      +++ .+..=.++.|..+....++..|....+.++.|-|+..
T Consensus       207 ~i~-~~~~vii~~~~~~~~~~~~~~~~~~gl~~~~~v~i~~  246 (441)
T 1jdp_A          207 NIQ-ASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNI  246 (441)
T ss_dssp             HHH-HHCSEEEEESCHHHHHHHHHHHHHTTCTTTTCEEEEE
T ss_pred             Hhh-cCCcEEEEecCHHHHHHHHHHHHHcCCCCCCEEEEEE
Confidence            666 4433357788899999999999888999998988654

>4f11_A Gamma-aminobutyric acid type B receptor subunit 2; venus flytrap module, G-protein coupled receptor, signaling; 2.38A {Homo sapiens} PDB: 4f12_A*

Probab=83.82  E-value=1.9  Score=37.16  Aligned_cols=111  Identities=14%  Similarity=0.189  Sum_probs=77.6

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccc-cc--cchhhhhhhc--cCCccccccCCCcchhHHHHHhhcc
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDS-FI--FDHKYKSLLQ--NIPTRHIIAPVEDSRSVKRQLFRFK  160 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~-f~--~~~ky~~ll~--~~p~rh~~~~~~~~~~~~~~~~~~~  160 (202)
                      ..+|.+.+.|+.......+..++...+.+..+++++++ |.  +-...+..++  ++...... .+  ..+...++.+++
T Consensus       127 ~~~~~fr~~~~~~~~~~~~~~~~~~~g~~~v~ii~~~~~~g~~~~~~~~~~~~~~g~~v~~~~-~~--~~d~~~~l~~i~  203 (433)
T 4f11_A          127 KYPYFFRTVPSDNAVNPAILKLLKHYQWKRVGTLTQDVQRFSEVRNDLTGVLYGEDIEISDTE-SF--SNDPCTSVKKLK  203 (433)
T ss_dssp             TCTTEEESSCCGGGHHHHHHHHHHHTTCCEEEEEEESSHHHHHHHHHHHHHSSSSSCEEEEEE-EE--SSCCHHHHHHHH
T ss_pred             cCCceEEecCchHHHHHHHHHHHHHcCCcEEEEEEecchhhHHHHHHHHHHHHHcCceEEEEe-cc--CcCHHHHHHHHh
Confidence            34788998888777777788888899999999998763 11  1111222222  11111000 00  135677888888


Q ss_pred             cCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEee
Q psy12232        161 DLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAIT  199 (202)
Q Consensus       161 ~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~~  199 (202)
                      +.+.--+|+.|.......++..|....+.++.|-|....
T Consensus       204 ~~~~~vii~~~~~~~~~~~~~~a~~~g~~~~~~~~i~~~  242 (433)
T 4f11_A          204 GNDVRIILGQFDQNMAAKVFCCAYEENMYGSKYQWIIPG  242 (433)
T ss_dssp             HTTCCEEEEECCHHHHHHHHHHHHHTTCCSTTCEEEEES
T ss_pred             hCCCeEEEEeCcHHHHHHHHHHHHHcCCCCCCeEEEEcC
Confidence            888777889999999999999999999999988887643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=83.80  E-value=0.36  Score=42.41  Aligned_cols=25  Identities=4%  Similarity=0.116  Sum_probs=22.0

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhh
Confidence            3678999999999999999998763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=83.43  E-value=0.26  Score=41.57  Aligned_cols=24  Identities=13%  Similarity=0.170  Sum_probs=21.2

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLV   25 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv   25 (202)
                      .+.+|+.+||..+|.+|||+.+++
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHh
Confidence            367899999999999999988764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=83.25  E-value=0.37  Score=42.79  Aligned_cols=26  Identities=27%  Similarity=0.353  Sum_probs=22.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||..+++.+
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            36789999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=83.07  E-value=0.58  Score=41.85  Aligned_cols=26  Identities=12%  Similarity=0.218  Sum_probs=22.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||..+++++
T Consensus       267 ~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHCCCChhhCccHHHHhcC
Confidence            36789999999999999999998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=82.99  E-value=0.42  Score=40.93  Aligned_cols=25  Identities=8%  Similarity=0.084  Sum_probs=21.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+|+.+||..+|.+|||..+++.
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3568999999999999999987764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=82.79  E-value=0.61  Score=41.02  Aligned_cols=24  Identities=13%  Similarity=0.212  Sum_probs=21.1

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+||..+|.+|||..++++
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            568999999999999999987764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=82.18  E-value=0.43  Score=41.07  Aligned_cols=26  Identities=12%  Similarity=0.027  Sum_probs=22.6

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||..+++.+
T Consensus       260 ~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            36789999999999999999988654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=82.07  E-value=0.68  Score=40.74  Aligned_cols=24  Identities=8%  Similarity=0.224  Sum_probs=21.3

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+|+..+|.+|||..++++
T Consensus       373 ~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          373 AIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCccccCCHHHHhc
Confidence            568999999999999999987764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=81.45  E-value=0.62  Score=40.39  Aligned_cols=24  Identities=8%  Similarity=0.131  Sum_probs=21.2

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+||..+|.+|||+.+++.
T Consensus       249 ~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          249 AKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhc
Confidence            568999999999999999987763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=81.02  E-value=0.64  Score=41.70  Aligned_cols=26  Identities=15%  Similarity=0.162  Sum_probs=22.7

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSK   27 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~   27 (202)
                      .+.+++.+||..+|.+|||..+++.+
T Consensus       277 ~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          277 EAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            35689999999999999999998753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	202
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-05
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-04
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	0.002
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	0.003
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	0.004

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 9e-05
 Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 4/50 (8%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLD 53
           YE+M  CW   A  RP F +LVS++  I     + ++G+ Y+ + A  ++
Sbjct: 264 YEVMLKCWHPKAEMRPSFSELVSRISAIF----STFIGEHYVHVNATYVN 309

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 3e-04
 Identities = 19/33 (57%), Positives = 24/33 (72%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTA 36
           Y +MRDCW  V S+RP F QLV  LDRI+ +T+
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.5 bits (81), Expect = 0.002
 Identities = 16/74 (21%), Positives = 29/74 (39%), Gaps = 6/74 (8%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSEDESN 63
           Y +M  CW   A  RP+F +L+ +  ++          Q YL ++       PS  D + 
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP------QRYLVIQGDERMHLPSPTDSNF 296

Query: 64  DDEETCAYLLESVI 77
                    ++ V+
Sbjct: 297 YRALMDEEDMDDVV 310

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.0 bits (80), Expect = 0.003
 Identities = 14/32 (43%), Positives = 17/32 (53%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVT 35
           Y+LMR CW     +RP F  L S L+   T T
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.7 bits (79), Expect = 0.004
 Identities = 15/42 (35%), Positives = 20/42 (47%)

Query: 4   YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYL 45
           ++LM  CW     ERP F  L + L+   T T  +Y   E L
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	202
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	97.82
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	92.26
d1ewka_	477	Metabotropic glutamate receptor subtype 1 {Rat (Ra	89.45
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	89.33
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	88.5
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	87.08
d1jdpa_	401	Hormone binding domain of the atrial natriuretic p	85.89
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	85.6
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	85.09
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	83.85
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	83.82
d1m6ya2	192	TM0872, methyltransferase domain {Thermotoga marit	83.4
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	83.38
d1dp4a_	425	Hormone binding domain of the atrial natriuretic p	83.08
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	81.95

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.82  E-value=1.8e-06  Score=72.38  Aligned_cols=36  Identities=25%  Similarity=0.599  Sum_probs=32.5

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHHHHHHHhhhhcc
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVSKLDRILTVTAN   37 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~~Le~ll~~~~~   37 (202)
                      .+++||.+||+.+|.+||||.+|+..|..+.+++..
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~  276 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  276 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHh
Confidence            478999999999999999999999999998876643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=92.26  E-value=0.019  Score=47.32  Aligned_cols=25  Identities=16%  Similarity=0.328  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHHh
Confidence            4679999999999999999998854

>d1ewka_ c.93.1.1 (A:) Metabotropic glutamate receptor subtype 1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Periplasmic binding protein-like I
superfamily: Periplasmic binding protein-like I
family: L-arabinose binding protein-like
domain: Metabotropic glutamate receptor subtype 1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=89.45  E-value=0.3  Score=41.34  Aligned_cols=111  Identities=14%  Similarity=0.155  Sum_probs=77.1

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecccccccchh---hhhhhc--cCCc--cccccCCCcchhHHHHHhhc
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHK---YKSLLQ--NIPT--RHIIAPVEDSRSVKRQLFRF  159 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d~~f~~~~k---y~~ll~--~~p~--rh~~~~~~~~~~~~~~~~~~  159 (202)
                      -+|.+...|+....-.++.++++..|-+..++++.+.-.-..-   .+..++  ++-.  ...+..-....++.+.++++
T Consensus       163 yp~f~Rt~psd~~~~~ai~~ll~~f~W~~V~vi~~~d~~g~~~~~~l~~~~~~~~i~v~~~~~i~~~~~~~~~~~~l~~l  242 (477)
T d1ewka_         163 YKYFLRVVPSDTLQARAMLDIVKRYNWTYVSAVHTEGNYGESGMDAFKELAAQEGLCIAHSDKIYSNAGEKSFDRLLRKL  242 (477)
T ss_dssp             CTTEEESSCCHHHHHHHHHHHHHHTTCCEEEEEEESSHHHHHHHHHHHHHHHHHTCEEEEEEEECTTCCHHHHHHHHHHH
T ss_pred             CCceEEecccchhhHHHHHHHHHHcCCcEEEEEEecchhHHHHHHHHHHHHHHcCcEEEEEeeccCCCchhhHHHHHHHH
Confidence            3567777887777778899999999999999998654221122   222222  3333  33333333467888999998


Q ss_pred             ccC--ceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        160 KDL--DIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       160 ~~~--d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ++.  +..=.++.+..+++..+|.+|...+++|+. -|...
T Consensus       243 ~~~~~~~rVIv~~~~~~~~~~ll~~a~~~g~~g~~-~~i~~  282 (477)
T d1ewka_         243 RERLPKARVVVCFCEGMTVRGLLSAMRRLGVVGEF-SLIGS  282 (477)
T ss_dssp             HTTTTTCCEEEEECCHHHHHHHHHHHHHHTCCSCC-EEEEC
T ss_pred             hhhccCceEEEEecCHHHHHHHHHHHHHcCccCCc-eEEEe
Confidence            865  555577889999999999999999999874 45543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=89.33  E-value=0.064  Score=43.91  Aligned_cols=25  Identities=16%  Similarity=0.118  Sum_probs=21.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+|+.+||..+|.+|||+.|+++
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            3568999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.50  E-value=0.1  Score=43.15  Aligned_cols=25  Identities=12%  Similarity=0.201  Sum_probs=22.3

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+|+.+|+..+|.+|||+.+++.
T Consensus       247 ~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         247 EVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHc
Confidence            3678999999999999999998865

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=87.08  E-value=0.11  Score=43.42  Aligned_cols=25  Identities=12%  Similarity=0.101  Sum_probs=21.8

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+|+.+||..+|.+|||..++++
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            3568999999999999999988754

>d1jdpa_ c.93.1.1 (A:) Hormone binding domain of the atrial natriuretic peptide receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Periplasmic binding protein-like I
superfamily: Periplasmic binding protein-like I
family: L-arabinose binding protein-like
domain: Hormone binding domain of the atrial natriuretic peptide receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.89  E-value=0.53  Score=37.04  Aligned_cols=111  Identities=14%  Similarity=0.174  Sum_probs=71.5

Q ss_pred             ccceEeeCCCCCChHHHHHHHHHHhcCCcceeecc-cccccch--hhhhhhccCCcccc----ccCCC-cchhHHHHHhh
Q psy12232         87 MKYLIQVNPPGDILPEVIRAIILMQNITDAGILFD-DSFIFDH--KYKSLLQNIPTRHI----IAPVE-DSRSVKRQLFR  158 (202)
Q Consensus        87 ~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~d-~~f~~~~--ky~~ll~~~p~rh~----~~~~~-~~~~~~~~~~~  158 (202)
                      .+|.+.+.|+....-+.+..++...+....+++++ +.|.-+.  -.+.+++......+    ..... +...... +.+
T Consensus       126 ~~~~fr~~~~~~~~~~al~~~l~~~~~~~v~il~~~d~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  204 (401)
T d1jdpa_         126 YSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLED-IVR  204 (401)
T ss_dssp             TTTEEECSCCHHHHHHHHHHHHHHHTCCEEEEEEECCSSSCHHHHHHHHHHHHHHHHTCEEEEEEECTTSCCCHHH-HHH
T ss_pred             CCeEEEeccchHHHHHHHHHHHHhcCCcEEEEEEecCcccchHHHHHHHHHHHhccceEEEEeeccccCchhHHHH-HHH
Confidence            36788888877767777888899999999888885 4444221  12223321111111    11111 2233333 333


Q ss_pred             cccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        159 FKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       159 ~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      ....+...++++|.......++.++....+.+.+|.|..+
T Consensus       205 ~~~~~~~~iv~~~~~~~~~~i~~~~~~~g~~~~~~~~i~~  244 (401)
T d1jdpa_         205 NIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNI  244 (401)
T ss_dssp             HHHHHCSEEEEESCHHHHHHHHHHHHHTTCTTTTCEEEEE
T ss_pred             hhccCceeEEEEechHHHHHHHHHHHHhCCCCCCeEEEee
Confidence            3445666778889999999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.60  E-value=0.19  Score=40.93  Aligned_cols=24  Identities=13%  Similarity=0.097  Sum_probs=21.4

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +-+|+.+|+..+|.+|||..++++
T Consensus       277 ~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         277 AVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhc
Confidence            457999999999999999998875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=85.09  E-value=0.11  Score=43.33  Aligned_cols=25  Identities=4%  Similarity=0.116  Sum_probs=21.9

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+|+.+||..+|.+|||+.++++
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            3678999999999999999988853

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.85  E-value=0.17  Score=41.47  Aligned_cols=25  Identities=4%  Similarity=0.001  Sum_probs=22.4

Q ss_pred             hHHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          2 SSYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         2 ~LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      ++.+++.+|+..+|.+|||+.++++
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            3568999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.82  E-value=0.16  Score=41.70  Aligned_cols=24  Identities=13%  Similarity=0.189  Sum_probs=21.5

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+|+.+|+..+|.+|||..|+++
T Consensus       279 ~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         279 AIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            568999999999999999998764

>d1m6ya2 c.66.1.23 (A:2-114,A:216-294) TM0872, methyltransferase domain {Thermotoga maritima [TaxId: 2336]}

class: Alpha and beta proteins (a/b)
fold: S-adenosyl-L-methionine-dependent methyltransferases
superfamily: S-adenosyl-L-methionine-dependent methyltransferases
family: MraW-like putative methyltransferases
domain: TM0872, methyltransferase domain
species: Thermotoga maritima [TaxId: 2336]

Probab=83.40  E-value=0.64  Score=35.88  Aligned_cols=84  Identities=15%  Similarity=0.206  Sum_probs=68.4

Q ss_pred             HHHHHHHHhcCCcceeecccccccchhhhhhhccCCccccccCCCcchhHHHHHhhcccCceeeeeeecchhhHHHHHhh
Q psy12232        103 VIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFILGRLQTIKMILDS  182 (202)
Q Consensus       103 ~vr~~~~~~nit~Agi~~d~~f~~~~ky~~ll~~~p~rh~~~~~~~~~~~~~~~~~~~~~d~~n~f~~g~~~~~~~~l~~  182 (202)
                      ..+.++...+..+.++++|-+|.---.-+.+|++.|--++++-=.+.+.++.--+++++.+-.-.|+-|++..++.++..
T Consensus        11 ll~evi~~l~~~~~~~~lD~t~G~Gghs~~il~~~~~~~vi~~D~d~~~l~~a~~~l~~~~~r~~~~~~~f~~~~~~~~~   90 (192)
T d1m6ya2          11 MVREVIEFLKPEDEKIILDCTVGEGGHSRAILEHCPGCRIIGIDVDSEVLRIAEEKLKEFSDRVSLFKVSYREADFLLKT   90 (192)
T ss_dssp             THHHHHHHHCCCTTCEEEETTCTTSHHHHHHHHHCTTCEEEEEESCHHHHHHHHHHTGGGTTTEEEEECCGGGHHHHHHH
T ss_pred             HHHHHHHhhCCCCCCEEEEecCCCcHHHHHHHhcCCCCeEEEeechHHHHHHHHHhhccccccccchhHHHhhHHHHHHH
Confidence            46677778888888999999999998899999999988877766677777777777777766677899999999999877


Q ss_pred             hhhh
Q psy12232        183 ANVN  186 (202)
Q Consensus       183 ~~~~  186 (202)
                      ...+
T Consensus        91 ~~~~   94 (192)
T d1m6ya2          91 LGIE   94 (192)
T ss_dssp             TTCS
T ss_pred             cCCC
Confidence            5543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.38  E-value=0.22  Score=40.87  Aligned_cols=23  Identities=9%  Similarity=0.083  Sum_probs=20.8

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLV   25 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv   25 (202)
                      +.+|+.+|+..+|.+|||..|++
T Consensus       287 ~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         287 ARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHHCcCChhHCcCHHHHh
Confidence            46799999999999999999875

>d1dp4a_ c.93.1.1 (A:) Hormone binding domain of the atrial natriuretic peptide receptor {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Periplasmic binding protein-like I
superfamily: Periplasmic binding protein-like I
family: L-arabinose binding protein-like
domain: Hormone binding domain of the atrial natriuretic peptide receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=83.08  E-value=1.3  Score=35.08  Aligned_cols=112  Identities=11%  Similarity=0.098  Sum_probs=71.4

Q ss_pred             cccceEeeCCCCCChHHHHHHHHHHhcCCcceeec-ccccccchhhhhhhcc----------CCccccccCCCcchhHHH
Q psy12232         86 QMKYLIQVNPPGDILPEVIRAIILMQNITDAGILF-DDSFIFDHKYKSLLQN----------IPTRHIIAPVEDSRSVKR  154 (202)
Q Consensus        86 ~~~YLlqv~pp~~~~pe~vr~~~~~~nit~Agi~~-d~~f~~~~ky~~ll~~----------~p~rh~~~~~~~~~~~~~  154 (202)
                      .-+|.+...|+......++..+++..+.+..++++ ++.+..++.+...++.          +........-.+.+.+..
T Consensus       119 ~~~~~~r~~p~~~~~~~~~~~~l~~~~~~~vaii~~~d~~g~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  198 (425)
T d1dp4a_         119 EYALTTRTGPSHVKLGDFVTALHRRLGWEHQALVLYADRLGDDRPCFFIVEGLYMRVRERLNITVNHQEFVEGDPDHYPK  198 (425)
T ss_dssp             TSTTEEECSCCHHHHHHHHHHHHHHHTCCSEEEEEEECCSSSCCHHHHHHHHHHHHHHHHHCCEEEEEEECTTCGGGHHH
T ss_pred             cCCccccccccchHHHHHHHHHHHhccCceEEEEEeccccccchhhHHHHHHHHHHHHHhcceEEeeeeecCCchhHHHH
Confidence            34567888877666777889999999999988777 4566655544433221          111111111112334444


Q ss_pred             HHhhcccCceeeeeeecchhhHHHHHhhhhhhhcccccceeEEe
Q psy12232        155 QLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGRKFAWHAI  198 (202)
Q Consensus       155 ~~~~~~~~d~~n~f~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~  198 (202)
                      -+++.+.. ..-+++++.......++..|....++|++|.|...
T Consensus       199 ~~~~~~~~-~~~vi~~~~~~~~~~~~~~a~~~g~~~~~~v~i~~  241 (425)
T d1dp4a_         199 LLRAVRRK-GRVIYICSSPDAFRNLMLLALNAGLTGEDYVFFHL  241 (425)
T ss_dssp             HHHHHHHH-CSEEEEESCHHHHHHHHHHHHHTTCCTTTCEEEEE
T ss_pred             HHHHhhhc-ceeEEEecchhHHHHHHHHHHHhCCCCCceEEEEe
Confidence            44443332 33345678889999999999999999999999764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.95  E-value=0.33  Score=39.61  Aligned_cols=24  Identities=17%  Similarity=0.313  Sum_probs=21.7

Q ss_pred             HHHHHHHhchhcCCCCCCHHHHHH
Q psy12232          3 SYELMRDCWSYVASERPEFIQLVS   26 (202)
Q Consensus         3 LY~LM~~CW~~dP~~RPtF~eLv~   26 (202)
                      +.+++.+|+..+|.+|||..++++
T Consensus       271 ~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         271 ALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            568999999999999999998864